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Abstract
Nitropolycyclic aromatic hydrocarbons are ubiquitous in the environment, and many compounds of this
family are carcinogenic. 6-Nitrochrysene, a representative member of this group, is a suspected human
carcinogen that has been shown to cause lung, breast, and other forms of cancer in rodents. It is believed
that this derivative of chrysene causes cancer by forming DNA adducts, which, in turn, induce mutations
in critical gene sequences. The goal of my research is to synthesize one or more of the major DNA
adducts formed by 6-nitrochrysene, which will be introduced in DNA in order to study their biological
effects.

The initiation step of the multi-step process that leads to cancer involves mutations in DNA via erroneous
replication, which occurs when the body is unable to repair certain DNA damages. Accumulation of
these mutations in critical genes triggers a series of biological events, ultimately making the cell an
outlaw. Usually, there are specific processes the cell employs to repair DNA damages. Cancer-causing
agents, such as 6-nitrochrysene, are metabolically activated in a cell to electrophilic species, which induce
specific DNA damages resulting in a high frequency of mutations.

Understanding exactly how 6-nitrochrysene causes mutations will provide insight into how cancer by this
chemical is initiated.

In order to accomplish this, one must synthesize the damaged nucleoside and

incorporate it into a DNA fragment. In this thesis, two new schemes are presented to prepare the 6nitrochrysene-damaged DNA fragments.

I have completed the synthesis of the appropriately protected C8-dG 6-nitrochrysene adduct and its
subsequent incorporation into an oligonucleotide by using a solid phase synthesis approach.
adducted oligonucleotide will be used for structural and biological studies.

xi

This

I have also developed and refined a synthetic route towards the N2-dG adduct. In this novel scheme, the
precursor to the Buchwald-Hartwig coupling has been prepared, and the chrysene derivative is nearly
complete. The subsequent steps are expected to proceed in good to excellent yield.

xii

CHAPTER I
INTRODUCTION

1

1.1 DNA Damages
DNA acts as a carrier for all of the genetic information in an organism.

When a cell undergoes

replication, it is critical that the DNA undergoes faithful replication and pass the genetic information to
the subsequent generation. The process of DNA replication is semi-conservative, since each strand of the
double helix can act as a template for a new strand. This replication method gives the next generation one
of the old strands, along with a newly synthesized strand. Due to the high fidelity of DNA polymerase,
this process takes places with a very high degree of accuracy. However, the few errors that do occur
allow for the mutations necessary to produce a variety of species through evolution.[1]

DNA possesses a number of nucleophilic centers in its structure and is therefore very susceptible to attack
by various agents. These agents include, but are not limited to, ultraviolet light, natural and man-made
chemicals, ionizing radiation, and reactive oxygen species.[2] All of these agents can induce DNA
damages. The process by which the damage occurs can either be through direct reaction of the agent with
DNA, or through metabolic processes within the cell which activate the agent and enable it to react with
DNA. Chemical carcinogens are often metabolized by the cellular enzymes and are largely excreted.
However, some of these metabolites may still react with DNA. [3-6]

If the cell is damaged, multiple pathways are pursued to rectify the damage or to avoid further damage to
the organism. Among these is apoptosis, the process of programmed cell death. This can occur if the
damage is great enough to induce a double strand break. There is also cell cycle checkpoint activation,
which serves to halt the cell cycle at G1. Arrest of cell replication can occur through a variety of
pathways, but it primarily proceeds through ubiquitination of key phosphatases to mark them for
degradation. This triggers a series of cellular activities which serve to prevent the cell from transitioning
to S phase.[3]

2

Once damaged, there are a variety of repair
mechanisms which the cell can also utilize. Among
these are nucleotide excision repair (NER) and base
excision repair (BER) pathways. BER is usually
employed for small, non-helix-distorting lesions
within DNA (Figure 1).[7] In this process, DNA
glycosylases turn the damaged strand of the double
helix to face outside. Then the N-glycosidic bond of
the damaged base is cleaved, leaving an AP
(apurinic/apyrimidic) site. The AP site is cleaved
from the phosphodiester backbone, and the resulting
single-strand break is repaired either by short-patch
(single nucleotide) or long-patch (2-10 nucleotides)
BER. Current studies are attempting to determine what may be the deciding factor between these two
pathways, but as of now, no decisive conclusion has been reached. Pol β is the primary DNA polymerase
that repairs the strand in the short-patch pathway, although in
its absence, pol γ can take over. In the long-patch pathway,
pol δ and pol ε are the primary DNA polymerases; it should be
noted that pol β can also take part in long-patch repair. In
contrast, NER is employed to repair bulky or helix-distorting
DNA adducts (Figure 2).[8] NER is initiated when a helical
distortion is noted or when RNA polymerase stalls at some
type of DNA lesion during transcription. The former initiation
is referred to as GG-NER (global genomic NER) while the
latter is referred to as TC-NER (transcription-coupled NER).

3

They differ only in their methods of identifying DNA damages. Thereafter, both pathways undergo the
same process. DNA is unwound and a single-strand gap of 25-30 nucleotides around the damage is
excised. DNA polymerases (usually pol δ, ε, and/or κ) are recruited to repair the strand, following which
a ligase seals the nicks in the strand.

There is also a series of translesion synthesis (TLS) polymerases, which aid a cell in bypassing DNA
lesions.[4,9] They restart stalled replications sites, but the major consequence of these polymerases are
their higher rates of errors and aptitude for introducing mutations in the DNA sequence.[9a,c] The five
known eukaryotic polymerases are Rev1, pol ζ, pol η, pol κ, and pol ι. These (with the exception of the
pol ζ, which is a B family polymerase) are part of the Y family of polymerases which are modified with
specialized structures to allow for the ability to read through bulky lesions, insert bases opposite them,
and carry out further extension.[9b] Their function is not to repair the damage, but to simply bypass the
lesion. This allows for survival through DNA replication as opposed to maintaining the accuracy of the
genetic information. Based on this, it is not surprising that DNA damage tolerance is often a mutagenic
process.[9d] Replicative DNA polymerases make one error in 106-108 bases, while TLS polymerases make
errors once every 10-103 bases. This reduced fidelity is likely due in part to some of the polymerases not
using canonical Watson-Crick base pairing (ex. pol ι and Rev1), whereas some do not undergo an induced
fit upon nucleotide binding and may involve a limited contact with the template base. Altogether, cells’
development of TLS polymerases to bypass DNA lesions and allow for restarting of stalled replication
forks comes at the cost of higher mutational frequencies. Elaborate regulatory mechanisms are in place to
limit the amount of mutations introduced during replication and this subject is still being investigated.[9e]

4

1.2 Polycyclic Aromatic Hydrocarbons
Polycyclic aromatic hydrocarbons (PAHs) are a
family of compounds comprising hydrocarbons in
multiple aromatic rings (Figure 3).[6] This family
has been studied extensively and a number of its
members have been associated with various
carcinogenic effects in biological systems.[10] The
first chemical carcinogen discovered was benzo[a]pyrene, one of the many chemical carcinogens present
in cigarette smoke. Since then, the EPA has classified several PAHs as probable human carcinogens:
benz[a]anthracene,

benzo[a]pyrene,

benzo[b]fluoranthene,

dibenz[a,h]anthracene, and indeno[1,2,3-cd]pyrene.

benzo[k]fluoranthene,

chrysene,

All of these are on the EPA’s list of priority

pollutants and are often targeted for measurement in environmental samples.[11,12]

A subfamily of the PAHs is the nitro-PAHs. Nitropolycyclic aromatic hydrocarbons were first studied
intensively when 4-nitroquinoline-1-oxide (4-NQO) was reported as a potent carcinogen.[11] After the
finding that this compound is carcinogenic, a number of other nitro-PAHs were found to be carcinogenic.
In fact, the nitrated versions of the original PAHs proved to be even more carcinogenic than their unsubstituted counterparts. Members of this subfamily are easily found in various environmental samples,
thereby warranting the extensive studies on their potential biological effects.

The original PAHs are capable of reacting with nitrogen oxides to form NO2-PAHs; this was first reported
by Pitts et al[11a] and Jager.[11b] These reactions proceed under conditions akin to polluted air and
combustion processes. As such, it is not surprising that the nitro-PAHs are commonly found in diesel
exhaust and cigarette smoke, along with coal fly ash, industrial waste, and refined oil products.
Additionally, some have also been found in the charred portion of certain grilled foods. As is clearly
demonstrated, human exposure to these compounds can occur through a variety of routes.
5

Multiple studies focusing on the public exposure to these carcinogens determine that several occupational
groups are at a considerably higher risk for developing associated cancers. [5] These include coke oven
workers, steelworkers, furnace workers, asphalt workers, and the general public in cities with a high
degree of air pollution.

The occupational risks are directly associated with the complex mixtures

containing PAHs that these workers encounter on a day-to-day basis, which may include coal tar pitch,
coke oven tar, and crumb rubber asphalt.[6] As expected, smokers also belong to a high exposure
population.

1.3 Metabolic Activation of 6-Nitrochrysene

Human exposure to these carcinogens occurs primarily through inhalation but also by ingestion and
dermal contact. Once introduced into the body, the polycyclic aromatic hydrocarbons are capable of
being biologically activated through metabolism.[13,14] The process of metabolism of each of the PAHs
usually results eventually in what is referred to as the “ultimate carcinogen”, the most reactive and
mutagenic derivative of the PAH.[13a] Usually, the original PAH – such as pyrene or chrysene – is not
nearly as carcinogenic as some of its derivatives.

Chrysene in particular is notably less carcinogenic than its nitrated from.[13b-d] It is commonly found in
exhaust mixtures of high temperature, such as coke oven exhaust or consumed engine oil. Although the
abundance of 6-nitrochrysene is far reduced compared to other members of its family, it is the most potent
tumor-inducing agent in animal studies among all tested nitroaromatic compounds.[13]

It also exhibits

one of the highest carcinogenic potencies in experimental animals among a broad spectrum of PAH
metabolites.

6

There are various pathways of metabolic activation
for a given PAH.

These include (1) metabolic

oxidation using cytochrome P450 to form PAH
radical cations, (2) creation of PAH-o-quinones via
dihydrodiol dehydrogenase, and (3) formation of
dihydrodiol epoxides via cytochrome p450 enzymes.

Most commonly, metabolic activation occurs

through the formation of bay-region dihydrodiol epoxides.[15] These species are extremely reactive and
can covalently bind to DNA to form the DNA damages discussed earlier. The PAH diol epoxides
(PAHDE) are further classified into groups based on the surrounding rings. There can be fjord, bay, and
k-region modifications (Figure 4).[16] Both the bay and fjord complexes can form PAHDEs while the K
region forms (predominantly) the epoxide (Figure 5). The PAHs with a fjord region typically show a
high rate of tumorigenicity. Due to the placement of the epoxide and hydroxyl moieties, the planarity of
the ring system cannot be maintained. These species are very
reactive and tend to preferentially bind to adenines.

In

contrast, PAHs with a bay region are less reactive than the
fjord region compounds. Due to the location of the hydroxyl
and epoxide moieties on the outer ring, the entire compound
is able to remain planar.

As a consequence of reduced

activity, these derivatives are generally seen binding to
guanine bases upon DNA adduct formation.

The metabolic pathway of 6-NC is shown in Figure 6 (adapted from Boyiri et al.).[14c] There are two
predominant routes though which 6-NC can be metabolized: dihydroxylation and reduction.[17] The
dihydroxylative pathway produces a variety of activated products through combinations of ring
epoxidation and nitroreduction. The ring epoxidation occurs rapidly after dihydroxylation due to the
availability of the double bond in the ring that lost its aromaticity.
7

The diol-epoxides comprise the set of the most reactive 6-nitrochrysene derivatives. These have been
associated with multiple cases of malignant liver and lung cancers.[14] The other route occurs through
reduction, producing N-hydroxyaminochrysene.

This derivative is capable of forming a variety of

adducts as listed in Figure 6. Among these, are the N-(deoxyguanosine-8-yl)-6-aminochrsyene (C8-dG
adduct), 5-(deoxyguanosine-N2-yl)-6-aminochrysene (N2-dG adduct), and N-(deoxyinosin-8-yl)-6aminochrysene (C8-dI adduct). The latter adduct is believed to arise from deamination of the C8-dG
adduct.
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1.4 Buchwald-Hartwig Palladium Catalyzed Coupling Reactions

The key reaction in these syntheses is the formation of a C-N bond connecting the polycyclic aromatic
hydrocarbon to the guanine base (see Reference 18 for a list of syntheses that employ this approach for
similar substrates). This is accomplished via a Buchwald-Hartwig coupling reaction (Figure 7[19]). This
produces a new carbon-nitrogen bond between the carcinogen and the DNA base.[20]

The attachment points for each adduct vary. As such, the coupling reactants are modified to suit
individual adducts. The C8-dG adducts are connected at the C8 position of the guanine base. The aryl
carcinogen undergoes amination and the guanine base is brominated. To create the N2-dG adduct, the aryl
carcinogen must have a leaving group such as a halogen or trifluoromethanesulfonate (triflate) to react
with the free amine already present on the guanine base (Figure 8).

The general mechanism for this reaction was originally thought to be akin to other palladium-catalyzed
coupling reactions, which includes: oxidative insertion and reductive elimination, and the coupled C-N
9

bond is formed.[19, 20a] This implies that the original palladium catalyst begins in the zero oxidation state.
The first step of the catalytic cycle is oxidative insertion of the aryl halide or triflate, resulting in the
palladium increasing to a +2 oxidation state. Upon direct attack of the amine on the palladium, the halide
or triflate leaves and react with the strong base present in solution. Finally, upon reductive elimination,
the palladium catalyst returns to its zero oxidation state while producing the desired C-N bond. This is
the process presented in older literature such as Singh et al.[21]

More recently, the Hartwig, Blackmond, and Buchwald groups published a correction to this
mechanism.[22] After several structural and kinetic studies, they posited the mechanism shown in Figure
9. Here, there is a “dead-end step” with the equilibrium forming Pd(BINAP)2. In situ, this complex
forms and later dissociates to enter the catalytic cycle. Based on their studies, they believe that this is the
palladium source that undergoes oxidative addition with the aryl halide. Then, upon addition of the base,
the catalytic cycle proceeds as expected with the coordination of the amine with the Pd(II) complex. This
is, of course, followed by reductive elimination of the desired product and regeneration of the Pd(BINAP)
complex which can resume the catalytic
cycle.

The reactions require both a chelating
ligand and an appropriate palladium
catalyst along with a strong base.
Originally, the purpose of the strong base
was to avoid the use of aminotin species,
which are heat and moisture-sensitive
species. The strong base most commonly
used is sodium tert-butoxide and this is
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the base used in all the syntheses presented here. The ligand and metal catalyst work together in a
complex in situ.

The chelating ligand chosen for the coupling of guanine with varying chrysene

derivatives was 2,2’-bis(diphenylphosphino)-1,1’-binapthyl (BINAP), depicted in Figure 10. Finally, the
palladium catalyst used was tris(dibenzylideneacetone)dipalladium(0), Pd2dba3. These two choices are
the most common choices for couplings of this nature, and were the first chosen for these syntheses.
Since the reactions proceeded in good yield, other combinations of bases, ligands, and catalysts were not
attempted.

1.5 Solid-Phase Oligonucleotide Synthesis

Ultimately, the DNA adducts prepared must undergo solid-phase oligonucleotide synthesis.[23] This is a
process to create a very specific oligonucleotide, containing the specially prepared DNA adduct
monomer.

Generally speaking, the oligomer chosen for my work was taken from the p53 tumor

suppressor gene, and the length of the oligomer chosen was based on the type of biological study that will
be performed. However, in order to properly incorporate the DNA adduct into the oligonucleotide, it
must be prepared with appropriate protecting groups.

Specifically in terms of a deoxyguanosine adduct, the 3’- and 5’-OH groups must be protected along with
the N2 amino group (Figure 11). It should be noted that, in the case of the N2-dG adducts, the N2
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protection is omitted since the carcinogen is present at that position. The 5’-OH must be protected with
an acid labile group. Traditionally, this has always been an MMtr[24a] or DMTr[24b] group. Since the
DMTr protecting group has far more selectivity towards primary hydroxyls over secondary hydroxyls, its
use has become more prevalent. The 3’-OH group is always protected with a phosphoramidite group.[23]
This group is specific for oligonucleotide synthesis and allows for the generation of the phosphodiester
linkage between the ribose sugars and is capable of undergoing oxidation to produce the sugar-phosphate
backbone. Finally, the N2 amine on the guanosine base must be protected with a base labile group. [23]
Historically, this was accomplished via an isobutyryl protection.[25] In recent years, a shift towards a
DMF acetal protection has occurred since the latter group is far more labile during the deprotection step
of the solid phase synthesis.[26] In the example presented in Figure 11, a DMF acetal group is present on
the undamaged deoxyguanosine base.

Upon appropriate protection of the
DNA adduct, the singular base is put
through solid-phase oligonucleotide
synthesis. This is a cyclic process
that couples a series of individual
bases to each other, resulting in the
desired oligomer.[23] As represented
in Figure 12, the cycle begins with a protected base. The first step is detritylation, where the DMTr group
on the 5’-OH is removed with a dilute acid. The free hydroxyl is then able to undergo coupling with the
next base. This occurs through nucleophilic attack on the phosphorus of the incoming base and loss of a
diisopropyl amine. The resulting bond is a phosphate linkage between two ribose sugars. The coupling
step is generally expected to proceed in excellent yield (in the vicinity of 99.5%), but it is unreasonable to
expect full conversion. As such, it is expected that there are some remaining 5’-OH groups that haven’t
coupled with the next base in the sequence. They cannot be allowed to continue to the next step in the
12

cycle, otherwise, they would from an oligomer with a deletion mutation. To avoid this, a capping step is
introduced at this point in the cycle. Capping is essentially a process to “protect” the 5’-OH group, and
prevent it from reacting further. It is usually accomplished via an N-methylimidazole or acetate group.
The final step is oxidation of the phosphorus in the newest base was introduced to the oligomer; as seen in
Figure 12, a double bond to an additional oxygen atom is observed. Once this has been completed, the nmer will continue onto the next cycle for introduction of the next base. This process continues until the
desired oligomer has been produced.
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CHAPTER II
SYNTHESIS OF THE C8
PHOSPHORAMIDITE MONOMER OF
8-(N-6-AMINOCHRYSENE)-N2-DMF-5’O-(4,4’-DIMETHOXYTRITYL)-2’DEOXYGUANOSINE
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2.1 Scheme for the 6-NC C8-dG Phosphoramidite Monomer
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2.2 Materials and Methods

MATERIALS

Bulk solvents and chemicals were purchased either from Sigma Aldrich (St. Louis, MO) or Fisher
Scientific (Clifton, NJ). Deuterated solvents were purchased from Cambridge Isotope Laboratories
(Andover, MA). The 2’-deoxyguanosine was purchased from Berry and Associates (Dexter, MI). Every
reagent used was obtained in the highest purity available. Both flash chromatography silica gel and
gravitational chromatography silica gel were purchased from Sorbent Technology (Norcross, GA).

SPECTROSCOPIC METHODS

NMR: NMR spectra were recorded as indicated on a Bruker 300, 400, or 500 MHz spectrometer.

1

H

chemical shifts are reported in parts per million relative to the residual chloroform (δ 7.26 ppm) or
dimethyl sulfoxide (δ 2.50 ppm) peak. The 13C-NMR values were referenced to the residual chloroform
(δ 77.1 ppm) or dimethyl sulfoxide (δ 39.52 ppm) peak. The

31

P-NMR shifts are reported as obtained

from the spectrometer. The 19F-NMR values are reported as obtained from the spectrometer. 1H-NMR
shifts are reported as chemical shift δ, multiplicity(s, singlet; d, doublet, t, triplet; q, quartet; m, multiplet;
br., broad), relative integral, and assignment.
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P ROCEDURES

6-Nitrochrysene (2) – In a 50 mL round bottom flask equipped with a stirbar was taken chrysene (1, 1.00
g, 4.384 mmol) in glacial acetic acid (28 mL). The solution was stirred briefly in an oil bath at 40 oC. To
it a solution of fuming nitric acid (0.8 mL, 18.019 mmol) and concentrated sulfuric acid (1.0 mL, 18.760
mmol) in glacial acetic acid (8 mL) was slowly added dropwise. The reaction was allowed to stir for 20
mins at 40oC; within 5-10 mins, the reaction mixture turned yellow. After 20 mins, the solution was
allowed to cool to room temperature and the solution was filtered. The precipitate was washed with
acetic acid and allowed to dry over vacuum for 2 h. Following this, the compound was further dried in an
oven for 30 mins to afford the pure compound as a pale yellow solid (1.0701 g, 89% yield).

1

H-NMR (400 MHz, DMSO-d6) δ ppm 7.68-8.01 (m, 4H, C1-H, C2-H, C16-H, C17-H), 7.93 (m, 2H, C12-H,

C15-H), 8.37 (t, 1H, C6-H), 8.89-8.95 (m, 1H, C11-H), 9.01 (t, 1H, C18-H), 9.17 (m, 1H, C3-H), 9.60 (s, 1H,
C9-H)

6-Aminochrysene (3) – In a 25 mL round bottom flask quipped with a stirbar was taken 2 (100 mg, 0.366
mmol). The flask was placed under a N2 atmosphere, and to it was added ethanol (8.5 mL). The flask
was purged with N2 for 30 mins. At this time, hydrazine monohydrate (0.6 mL, 5.803 mmol) was added
to the flask, and the flask was purged for an additional 30 mins. After this, 10% wt palladium on carbon
(1.3 mg, 0.0265 mmol) was added to the flask, and the reaction was heated at reflux for 15 h. After this
time, the reaction flask was allowed to cool to room temperature, and the solvent was evaporated. The
crude product was loaded onto a silica gel plug and the desired compound eluted in neat dichloromethane.
The solvent was removed via rotary evaporation to afford the pure compound as a pale yellow solid (70.6
mg, 79% yield).
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1

H-NMR (400 MHz, DMSO-d6) δ ppm 6.03 (s, 2H, NH2), 7.60-7.78 (m, 5H, C1-H, C2-H, C9-H, C16-H,

C17-H), 7.95 (m, 1H, C11-H), 8.12 (m, 2H, C12-H, C15-H), 8.59-8.67 (dd, 1H, C6-H), 8.89 (d, 1H, C18-H),
8.95 (d, 1H, C3-H)

13

C-NMR (101 MHz, DMSO-d6) δ ppm 100.77, 121.08, 122.24, 122.72, 123.41, 123.69, 124.31, 124.60,

126.13, 126.54, 126.90, 127.42, 128.96, 129.33, 131.50, 131.67, 132.98, 144.51.

8-Bromo-2’-deoxyguanosine (5) – In a 500 mL Erlenmeyer flask equipped with a stirbar was taken 2’deoxyguanosine monohydrate, 4 (6.50 g, 24.323 mmol) suspended in 80% aqueous acetonitrile (300 mL)
at room temperature. Freshly recrystallized N-bromosuccinimide (6.493 g, 36.483 mmol) was added to
the stirring mixture in three aliquots over 30 mins. The reaction mixture was then stirred for an additional
30 mins. After this time, the reaction mixture was filtered through a Büchner funnel. The product was
washed with acetone to give 7.504 g (89% yield) of the product as a white flaky solid.

1

H-NMR (400 MHz, DMSO-d6) δ ppm 2.07-2.13 (ddd, 1H, C13-H), 3.12-3.19 (ddd, 1H, C13-H’), 3.33 (br.

s, 1H, O17-H), 3.48-3.52 (dd, 1H, C18-H), 3.60-3.64 (dd, 1H, C18-H’), 3.78-3.82 (q, 1H, C12-H), 4.38-4.41
(m, 1H, C16-H), 4.84 (br. s, 1H, O19-H), 6.14-6.17 (t, 1H, C14-H), 6.48 (br. s, 2H, N10-2H), 10.78 (s, 1H,
N1-H)

13

C-NMR (101 MHz, DMSO-d6) δ ppm 36.46 (C13), 62.05 (C18), 71.03 (C12), 85.06 (C14), 87.90 (C16),

117.49 (C5), 120.53 (C7), 151.98 (C4), 153.32 (C2), 155.42 (C6)

8-Bromo-3',5'-O-bis(tert-butyldimethylsilyl)-2'-deoxyguanosine (6) – In a 25 mL round bottom flask
equipped with a stirbar was taken 5 (907 mg, 2.62 mmol) and imidazole (852 mg, 12.52 mmol) in dry
DMF (10 mL) at room temperature. To the stirring reaction mixture was added tert-butyldimethylsilyl
chloride (1.085 g, 7.2 mmol). The solution turned transparent within 5 mins and was allowed to continue
18

stirring for 8 hrs. Once this time elapsed, the reaction was quenched with methanol. The solution was
evaporated and diluted with deionized water (25 mL) and methylene chloride (25 mL). The layers were
separated and the aqueous layer extracted with methylene chloride (2 x 25 mL). The crude product was
purified by silica gel flash column chromatography with a step gradient of methanol (0-10%) in
methylene chloride as the mobile phase. The product was isolated as a white solid (1.42 g, 94% yield).

1

H-NMR (400 MHz, DMSO-d6) δ ppm -0.04 (s, 3H, C23-3H), -0.02 (s, 3H, C24-3H), 0.09 (s, 6H, C29-3H,

C30-3H), 0.81 (s, 9H, C32-3H, C33-3H, C34-3H), 0.87 (s, 9H, C25-3H, C26-3H, C27-3H), 2.10-2.16 (ddd, 1H,
C13-H), 3.35-3.41 (ddd, 1H, C13-H’), 3.61-3.67 (m, 1H, C12-H), 3.73-3.79 (m, 2H, C18-2H), 4.58 (m, 1H,
C16-H), 6.13-6.16 (t, 1H, C14-H), 6.46 (br. s, 2H, N10-2H), 10.87 (s, 1H, N1-H)

13

C-NMR (101 MHz, DMSO-d6) δ ppm -5.50 (C29, C30), -4.94 (C23), -4.77 (C24), 17.63 (C31), 17.90 (C22),

25.63 (C32, C33, C34), 25.69 (C25, C26, C27), 36.07 (C13), 62.82 (C18), 72.38 (C12), 84.68 (C14), 87.12 (C16),
117.46 (C5), 120.40 (C7), 152.10 (C4), 153.38 (C2), 155.46 (C6)

O6-Benzyl-8-bromo-3',5'-O-bis(tert-butyldimethylsilyl)-2'-deoxyguanosine (7) – In a 50 mL round
bottom flask equipped with a stirbar was taken 6 (1.0 g, 1.74 mmol) and triphenylphosphine (800 mg,
3.04 mmol). The flask was placed under an N2 atmosphere, and to it was added dry dioxane (20 mL). To
the stirring reaction mixture at room temperature, benzyl alcohol (0.316 mL, 3.05 mmol) was added.
Diisoproyl azodicarboxylate (0.600 mL, 3.09 mmol) was added dropwise to the stirring mixture, which
turned to a transparent yellow within 15 mins. The reaction was allowed to continue stirring at room
temperature for 8 h under the N2 atmosphere. After this time, the solvent was evaporated. The crude
compound was purified by silica gel flash column chromatography with a step gradient of ethyl acetate
(0-15%) in hexanes as the mobile phase. The product was isolated as a light yellow solid (0.903 g, 78 %
yield).
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1

H-NMR (400 MHz, CDCl3) δ ppm -0.03 (s, 3H, C37-3H), 0.01 (s, 3H, C38-3H), 0.14 (s, 6H, C29-3H, C30-

3H), 0.84 (s, 9H, C39-3H, C40-3H, C41-3H), 0.93 (s, 9H, C31-3H, C32-3H, C33-3H), 2.13-2.18 (ddd, 1H, C13H), 3.50-2.56 (ddd, 1H, C13-H’), 3.67-3.71 (dd, 1H, C17-H), 3.83-3.93 (m, 2H, C12-H, C17-H), 4.78(dt, 1H,
C16-H), 5.51 (s, 2H, C19-2H), 6.25 (t, 1H, C14-H), 6.28 (br. s, 2H, N10-2H), 7.28-7.36 (m, 3H, C21-H, C23H, C25-H), 7.46 (m, 2H, C22-H, C24-H)
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C-NMR (101 MHz, CDCl3) δ ppm -5.45 (C37, C38), -4.66 (C29, C30), 18.00 (C36), 18.30 (C28), 21.90 (C39,

C40, C41), 25.80 (C31, C32, C33), 36.41 (C13), 62.64 (C17), 68.10 (C19), 72.30 (C12), 85.71 (C16), 87.37 (C14),
116.42 (C5), 126.90 (C7), 128.00 (C23), 128.27 (C25), 128.33 (C21), 128.47 (C24), 128.51 (C22), 136.12
(C20), 154.41 (C4), 158.38 (C2), 159.81 (C6)

O6-Benzyl-8-bromo-3',5'-O-bis(tert-butyldimethylsilyl)-N2-dimethoxytrityl-2'-deoxyguanosine (8) – In a
25 mL round bottom flask equipped with a stirbar was taken 7 (1.20 g, 1.80 mmol) in dry pyridine (15
mL). To this, was added some crystals of 4-dimethylaminopyrine. 4,4-Dimethoxytrityl chloride (0.92 g,
2.70 mmol) was added to the solution at room temperature and the reaction mixture was allowed to
continue stirring for 12 hrs. The reaction was checked for completion by TLC (80/20 Hexanes/EtOAc,
v/v). The solvent was evaporated and purified by aluminum oxide column chromatography with a step
gradient of ethyl acetate (0-10%) in hexanes as the mobile phase. The product was isolated as a
transparent solid (1.58 g, 91% yield).

1

H-NMR (400 MHz, DMSO-d6) δ ppm -0.11 (s, 3H, C48-3H), -0.05 (s, 3H, C47-3H), 0.10 (s, 6H, C56-3H,

C57-3H), 0.77 (s, 9H, C53-3H, C54-3H, C55-H), 0.87 (s, 9H, C49-3H, C50-3H, C51-3H), 3.32 (s, 2H, N10-H,
C12-H), 3.51-3.56 (m, 2H, C13-H, C18-H), 3.68 (s, 6H, C41-3H, C43-3H), 3.72-3.76 (m, 2H, C16-H, C18-H),
4.81 (br. s, 2H, C58-2H), 6.07 (t, 1H, C14-H), 6.79-6.85 (d, 4H, C26-H, C28-H, C36-H, C38-H), 6.87-6.91 (m,
1H, C62-H), 7.14-7.24 (m, 6H, C30-H, C34-H, C60-H, C61-H, C63-H, C64-H), 7.26-7.28 (d, 4H, C25-H, C29-H,
C35-H, C39-H), 7.30-7.32 (m, 3H, C31-H, C32-H, C33-H)
20

13

C-NMR (101 MHz, DMSO-d6) δ ppm -4.92 (C57), -4.79 (C56), -4.16 (C48), -4.02 (C47), 18.43 (C52),

18.56 (C46), 26.33 (C53, C54, C55), 26.36 (C49, C50, C51), 35.83 (C13), 55.66 (C41, C43), 62.83 (C12), 67.64
(C58), 70.24 (C18), 72.80 (C21), 85.95 (C16), 87.33 (C14), 113.57 (C26, C28, C36, C38), 115.63 (C5), 127.06
(C7), 128.26 (C32), 128.68 (C60, C62, C64), 128.72 (C31, C33), 129.05 (C25, C29, C35, C39), 129.08 (C61, C63),
130.37 (C30, C34), 136.72 (C59), 138.32 (C22, C24), 138.41 (C23), 146.41 (C2), 154.59 (C4), 157.66 (C6),
158.37 (C27, C37)

8-(N-6-Aminochrysene)-O6-benzyl-3',5'-O-bis(tert-butyldimethylsilyl)-N2-dimethoxytrityl-2'deoxyguanosine (9) – In a 25 mL round bottom flask equipped with a stirbar was taken 8 (531 mg, 0.548
mmol), 6-aminochrysene (3, 200 mg, 0.822 mmol), tris(dibenzylideneacetone)dipalladium(0) (Pd2(dba)3,
20 mg, 0.0219 mmol), and rac-2,2’-bis(diphenylphosphino)-1,1’-binaphthyl (BINAP, 40 mg, 0.0636
mmol), in dry toluene (5 mL). The solution was degassed by purging argon for one hour. The solution
was then heated at 90oC for one hour. At this point, sodium tert-butoxide (79 mg, 0.823 mmol) was
added, and the solution heated at 100oC for an additional hour.

The reaction was cooled, diluted with

ether (10 mL), and successively filtered through Celite®. The filtrate was evaporated and purified by
alumina oxide column chromatography with a step gradient of EtOAc (0-15%) in hexanes as the mobile
phase. The product was isolated as a dark yellow-green solid (354 mg, 57% yield).
1

H-NMR (400 MHz, CDCl3) δ ppm -0.27 (s, 3H, CH3), -0.19 (s, 3H, CH3), 0.12 (s, 6H, 2 x CH3), 0.64 (s,

9H, t-Bu-9H), 0.94 (s, 9H, t-Bu-9H), 2.26 (m, 1H, C2’-H), 2.88 (br. s, 1H, C2’-H), 3.80 (s, 6H, 2 x OMe),
3.82-3.95 (m, 2H, C5’-2H), 4.15 (q, 1H, C3’-H), 4.50 (br. s, 1H, C4’-H), 5.08 (br. s, 2H, Bn-CH2), 6.10 (s,
1H, N2-H), 6.22 (br. s, 1H, C1’-H), 6.80 (d, 4H, DMTr-4H), 7.14-7.25 (m, 9H, DMTr-9H), 7.29-7.44 (m,
5H, OBn-5H), 7.57-7.74 (m, 4H, CR-4H), 7.91-8.01 (m, 2H, CR-2H), 8.11 (d, 1H, CR-H), 8.37 (br. s,
1H, CR-H), 8.66 (d, 1H, CR-H), 8.77 (d, 1H, CR-H), 8.83 (d, 1H, CR-H), 9.52 (br. s, 1H, N8-H)
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C-NMR (101 MHz, CDCl3) δ ppm -5.78, -5.70, -4.74, -4.58, 18.00, 18.23, 25.66, 25.81, 55.14, 55.23,

63.15, 70.14, 72.59, 112.78, 112.81, 113.16, 120.88, 123.85, 126.29, 126.37, 127.51, 127.83, 128.12,
128.23, 129.02, 129.11, 130.19, 130.25, 130.40, 131.44, 132.37, 158.00
ESI-MS (positive mode): m/z calcd for C68H76N6O6Si2H+ 1129.5, observed 1129.9 Da [M+H]+
8-(N-6-Aminochrysene)-O6-benzyl-3',5'-O-bis(tert-butyldimethylsilyl)-2'-deoxyguanosine (10) – In a
100 mL round bottom flask equipped with a stirbar was taken 9 (1.976 g, 1.746 mmol). The compound
was dissolved in a minimal amount of methylene chloride (10 mL) and reacted with 0.01M methanolic
HCl (20 mL, 0.175 mmol). The mixture was stirred for 16 h and monitored by TLC (neat DCM). Upon
completion of the reaction, the solvent was evaporated and purified by silica gel flash column
chromatography with a gradient of methanol (0-5%) in dichloromethane as the mobile phase. The
product was isolated as a yellow solid (0.9697 g, 67% yield).
1

H-NMR (400 MHz, CDCl3) δ ppm -0.27 (s, 3H, CH3), -0.19 (s, 3H, CH3), 0.17 (s, 6H, 2 x CH3), 0.63 (s,

9H, t-Bu-9H), 0.97 (s, 9H, t-Bu-9H), 2.40 (ddd, 1H, C2’-H), 3.15 (ddd, 1H, C2’-H), 3.85 (m, 1H, C5’-H),
3.98 (m, 1H, C5’-H) , 4.17 (q, 1H, C4’-H), 4.64 (m, 1H, C3’-H), 4.78 (br. s, 2H, OBn-2H), 5.63 (br. s, 2H,
N2-2H), 6.47 (t, 1H, C1’H), 7.28-7.36 (m, 3H, OBn-Ar-3H), 7.52 (d, 2H, OBn-Ar-2H), 7.61-7.75 (m, 4H,
CR-4H), 7.93-7.99 (m, 2H, CR-2H), 8.14 (d, 1H, CR-H), 8.35 (br. s, 1H, CR-H), 8.67 (d, 1H, CR-H),
8.79-9.00 (m, 2H, CR-2H), 9.48 (s, 1H, N8-H)
13

C-NMR (101 MHz, CDCl3) δ ppm -5.93, -5.86, -4.87, -4.70, 17.86, 18.09, 25.49, 25.63, 39.16, 53.26,

62.92, 67.99, 72.24, 77.06, 85.01, 87.85, 112.55, 113.37, 120.75, 121.46, 123.69, 125.21, 125.86, 126.14,
126.17, 126.39, 126.89, 127.52, 127.86, 128.07, 128.11, 128.78, 130.23, 131.32, 132.22, 133.67, 136.89,
148.58, 153.86, 157.04, 158.06
ESI-MS (positive mode): m/z calcd for C47H58N6O4Si2H+ 827.4, observed 827.7 Da [M+H]+
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8-(N-6-Aminochrysene)-3',5'-O-bis(tert-butyldimethylsilyl)-2'-deoxyguanosine (11) – In a 50 mL round
bottom flask equipped with a stirbar was taken 10 (0.9697 g, 1.169 mmol) in anhydrous methanol (20
mL). The resulting solution was purged with N2 for 30 mins. At this point, palladium black (125 mg,
1.169 mmol) was added to the stirring solution. The reaction was purged with H 2 for an additional 2 h
and then left to stir under a hydrogen atmosphere for 12 h. The reaction mixture was monitored by TLC
(90:10 DCM/MeOH v/v). Once the reaction was complete, the solvent was evaporated and the crude
product purified via silica gel flash column chromatography with a step gradient of methanol (0-10%) in
dichloromethane. The final product was isolated as a white solid (755 mg, 88% yield).
1

H-NMR (400 MHz, CDCl3) δ ppm -0.29 (s, 3H, CH3), -0.22 (s, 3H, CH3), 0.14 (s, 3H, CH3), 0.15 (s, 3H,

CH3), 0.60 (s, 9H, t-Bu-9H), 0.95 (s, 9H, t-Bu-9H), 1.64 (m, 1H, C2’-H), 2.40 (m, 1H, C2’-H), 3.10 (m,
1H, C3’-H), 3.82-3.86 (m, 1H, C5’-H), 3.97-4.00 (m, 1H, C5’-H), 4.60 (m, 1H, C4’-H), 5.14 (s, 1H, N1-H),
5.60 (s, 2H, N2-2H), 6.46 (t, 1H, C1’-H), 7.60-7.76 (m, 4H, CR-4H), 7.94-7.99 (m, 2H, CR-2H), 8.13 (d,
1H, CR-H), 8.39 (br. s, 1H, CR-H), 8.68 (d, 1H, CR-H), 8.77 (d, 1H, CR-H), 8.84 (d, 1H CR-H), 9.38 (s,
1H, N8-H)
13

C-NMR (101 MHz, CDCl3) δ ppm -5.57, -5.47, -4.50, -4.33, 18.24, 18.50, 25.86, 26.00, 29.93, 39.63,

53.68, 63.33, 68.85, 72.67, 77.08, 77.47, 85.36, 88.34, 100.23, 114.15, 121.15, 122.05, 123.96, 124.07,
126.47, 126.64, 126.89, 128.02, 128.29, 128.48, 128.56, 130.59, 131.73, 132.60
ESI-MS (positive mode): m/z calcd for C40H52N6O2Si2H+ 737.4, observed 737.4 Da [M+H]+

8-(N-6-Aminochrysene)-3',5'-O-bis(tert-butyldimethylsilyl)-N2-DMF-2'-deoxyguanosine (12) – In a 50
mL round bottom flask equipped with a stirbar was taken 11 (755 mg, 1.024 mmol). The flask was
placed under a N2 atmosphere. To it was added anhydrous methanol (15 mL) and the solution was purged
for 15 mins with N2. After, N,N-dimethylformamide dimethyl acetal (0.6 mL, 4.097 mmol) was slowly
added dropwise to the solution. The solution was stirred was stirred for 40 hr. After the reaction was
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complete, the solvent was evaporated, and the crude product was purified via silica gel flash column
chromatography with a step gradient of methanol (0-10%) in dichloromethane to give the pure product as
a yellow solid in quantitative yield (811 mg, 100% yield).
1

H-NMR (400 MHz, CDCl3) δ ppm -0.35 (s, 3H, CH3), -0.25 (s, 3H, CH3), 0.09 (s, 6H, 2 x CH3), 0.57 (s,

9H, t-Bu-9H), 0.91 (s, 9H, t-Bu-9H), 2.27-2.32 (ddd, 1H, C2’-H), 2.78-2.85 (ddd, 1H, C2’-H), 3.07 (s, 3H,
DMF-CH3), 3.13 (s, 3H, DMF-CH3), 3.82-3.86 (m, 1H, C5’-H), 3.92-3.96 (m, 1H, C5’-H), 4.11 (q, 1H,
C4’-H), 4.50 (m, 1H, C3’H), 6.49 (t, 1H, C1’-H), 7.56-7.68 (m, 4H, CR-4H), 7.88-7.93 (m, 2H, CR-2H),
8.08 (d, 1H, CR-H), 8.20 (br. s, 1H, N1-H), 8.54 (s, 1H, CR-H), 8.61 (s, 1H, CR-H), 8.76 (t, 2H, CR-2H),
9.18 (br. s, 1H, N8-H)
13

C-NMR (101 MHz, CDCl3) δ ppm -5.81, -5.72, -4.73, -4.60, 17.94, 18.27, 25.63, 25.73, 31.39, 35.16,

36.43, 39.82, 41.26, 63.25, 72.68, 84.78, 88.03, 114.41, 120.83, 121.98, 123.72, 124.00, 125.50, 126.07,
126.17, 126.30, 126.44, 126.48, 128.13, 128.89, 130.28, 131.46, 132.27, 133.89, 147.58, 148.93, 154.68,
157.26, 162.47
ESI-MS (positive mode): m/z calcd for C43H57N7O4Si2H+ 792.4, observed 792.6 Da [M+H]+.

8-(N-6-Aminochrysene)-N2-DMF-2'-deoxyguanosine (13) – In a 50 mL round bottom flask was taken
12 (811 mg, 1.024 mmol). The flask was placed under a N2 atmosphere and to it was added anhydrous
tetrahydrofuran (25 mL).

To the stirring solution was added 1M tetrabutylammonium fluoride in

tetrahydrofuran (4.2 mL, 4.116 mmol). The reaction mixture immediately turned red after this addition.
The solution was allowed to stir for 15 h under N2. After this time, the solvent was evaporated and the
crude product was purified via silica gel flash column chromatography with methanol (0-20%) in
dichloromethane as the mobile phase. The pure product was afforded as a pale yellow solid (312.3 mg,
54% yield).
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1

H-NMR (400 MHz, DMSO-d6) δ ppm 2.22 (ddd, 1H, C2’-H), 2.98-3.05 (m, 1H, C2’-H), 3.05 (s, 3H,

DMF-CH3), 3.18 (s, 3H, DMF-CH3), 3.65-3.70 (m, 1H, C5’-H), 3.79-3.85 (m, 1H, C5’-H), 3.94 (m, 1H,
C4’-H), 4.51 (m, 1H, C3’-H), 5.32 (d, 1H, C3’-OH), 5.44 (t, 1H, C5’-OH), 6.50 (t, 1H, C1’-H), 7.66-7.80 (m,
4H, CR-3H and DMF-CH), 8.03-8.10 (m, 2H, CR-2H), 8.19 (d, 1H, CR-H), 8.56 (s, 1H, N1-H), 8.72 (m,
2H, CR-2H), 8.86 (d, 1H, CR-H), 9.00 (m, 2H, CR-2H), 11.23 (s, 1H, N8-H)
13

C-NMR (101 MHz, DMSO-d6) δ ppm 13.71, 18.68, 19.72, 23.62, 30.79, 34.94, 46.87, 49.18, 54.99,

58.23, 62.02, 67.58, 71.86, 84.10, 88.12, 114.15, 116.78, 121.66, 123.82, 124.11, 125.79, 126.61, 126.81,
127.09, 127.17, 127.49, 128.15, 128.75, 128.90, 130.17, 131.68, 132.66, 136.62, 147.72, 149.71, 156.49,
157.56, 158.20
ESI-MS (positive mode): m/z calcd for C31H29N7O4H+ 564.2, observed 586.3 Da [M+Na]+.
8-(N-6-Aminochrysene)-N2-DMF-5’-O-(4,4’-dimethoxytrityl)-2’-deoxyguanosine (14) – The product 13
of the preceding reaction was thrice azeotroped with anhydrous pyridine. In a 50 mL round bottom flask
equipped with a stirbar was taken 13 with 4-dimethylaminopyridine (DMAP, 5 mg, catalytic amt.). The
flask was placed under an argon atmosphere, and to it was added anhydrous pyridine (3 mL). To the
stirring solution was added 4,4’-dimethoxytrityl chloride (110 mg, 0.325 mmol). The reaction mixture
immediately turned a deep orange-yellow. Within one hour, the reaction mixture darkened to green.
Over the following 2 hr, the reaction mixture became brown. The reaction was monitored via TLC
(94:5:1 DCM/MeOH/NEt3). The reaction was stopped after 25 h and dried under nitrogen. The crude
product was purified via silica gel column chromatography (0-5 % methanol in methylene chloride
containing 1% NEt3). The product began eluting at approximately 5%. The pure product was isolated as
a pale yellow solid (138 mg, 80% yield).
1

H-NMR (400 MHz, CDCl3) δ ppm 2.83 (m, 1H, C2’-H), 3.08 (s, 3H, DMF-CH3), 3.24 (s, 3H, DMF-

CH3), 3.27-3.32 (m, 2H, C5’-2H), 3.45 (s, 3H, DMTr-OMe), 3.48 (s, 3H, DMTr-OMe), 3.71 (m, 1H, C4’H), 4.80 (m, 1H, C3’-H), 5.29 (s, 1H, C3’-OH), 6.34 (d, 2H, DMTr-2H), 6.38 (d, 2H, DMTr-2H), 6.74 (t,
25

1H, C1’-H), 7.01 (t, 3H, DMTr-3H), 7.07 (d, 2H, DMTr-2H), 7.11 (d, 2H, DMTr-2H), 7.41-7.56 (m, 4H,
DMF-H, CR-3H), 7.65-7.72 (m, 2H, DMTr-2H), 7.83 (s, 1H, N8-H), 7.87-7.94 (m, 4H, CR-4H), 8.35 (s,
1H, CR-H), 8.58 (d, 1H, CR-H), 8.74 (m, 2H, CR-2H).
13

C-NMR (101 MHz, CDCl3) δ ppm 13.22, 14.38, 19.26, 22.86, 23.58, 29.17, 33.81, 34.70, 38.69, 41.06,

54.41, 54.46, 58.51, 71.03, 83.35, 85.61, 86.01, 112.26, 115.52, 116.74, 119.98, 122.79, 123.46, 125.57,
126.20, 126.28, 126.44, 126.55, 127.16, 127.85, 128.12, 128.40, 129.24, 129.57, 130.58, 131.45, 133.80,
134.37, 142.72, 148.45, 149.50, 154.74, 156.38, 157.64, 157.72, 169.86.
ESI-MS (positive mode): m/z calcd for C52H47N7O6H+ 866.4, observed 888.6 Da [M+Na]+.
8-(N-6-amino-chrysene)-N2-DMF-5’-O-(4,4’-dimethoxytrityl)-3’-cyanoethyl-2’-deoxyguanosine
phosphoramidite (15) – The entirety of the reaction was completed in a glovebag. In a 50 mL round
bottom flask equipped with a stirbar was taken 14 (225 mg, 0.260 mmol) after having been dried
thoroughly. The flask was placed under an argon atmosphere, and the product of the previous reaction
was dissolved in anhydrous methylene chloride (3 mL). To the stirring solution was added anhydrous
N,N-diisopropylethylamine

(94

μL,

0.538

mmol),

followed

by

2-cyanoethyl-N,N-

diisopropylchlorophosphoramidite (60 μL, 0.260 mmol). The reaction mixture was allowed to stir for 15
mins. At this time, additional anhydrous N,N-diisopropylethylamine (94 μL, 0.538 mmol) was added to
the solution. The reaction was allowed to stir for an additional 15 mins, at which time it was stopped.
The solution was diluted with methylene chloride (15 mL) and saturated sodium bicarbonate (20 mL).
The organic layer was retained and the aqueous layer further extracted with methylene chloride (2 x 20
mL). The organic layers were combined and washed with brine (1 x 25 mL). The organic layer was dried
over sodium sulfate and the solvent removed by rotary evaporation to give the crude product as a yellowbrown solid. This was dissolved in minimal methylene chloride (2 mL) and added dropwise to a stirring
solution of hexanes (200 mL). The resulting precipitate was filtered out and collected. Any remaining
free phosphorus was removed via basified silica gel flash column chromatography with a step gradient of
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methanol (0-2%) in methylene chloride containing 1% triethylamine.

The product was isolated as a pale

yellow solid (145 mg, 52% yield).
1

H NMR (500 MHz, CDCl3, two diastereomers) δ 1.27 (m, 12H, 4 x iPr-CH3), 1.71 (m, 1H, C2’-H), 2.36

(t, 1H, -CH2CN), 2.52 (t, 1H, -CH2CN), 2.60-2.66 (m, 1H, P-O-CH2), 2.75 (td, 1H, P-O-CH2), 3.08 (s,
3H, DMF-CH3), 3.13 (s, 3H, DMF-CH3), 3.30 (m, 1H, C2’-H), 3.34-3.42 (m, 2H, C5’-2H), 3.47 (s, 3H,
DMTr-OCH3), 3.48 (s, 3H, DMTr-OCH3), 3.70 (m, 1H, C4’-H), 4.09-4.23 (m, 1H, P-N-CH), 4.30 (m, 1H,
C3’-H), 4.73-4.84 (m, 1H, P-N-CH), 6.43 (m, 4H, DMTr-4H), 6.53 (t, 1H, C1’-H), 7.06 (m, 3H, DMTr3H), 7.09-7.16 (m, 5H, DMTr-5H), 7.29 (m, 2H, DMTr-H, CR-H), 7.43 (m, 2H, CR-H, DMTr-H), 7.51
(t, 1H, CR-H), 7.65 (t, 1H, CR-H), 7.86 (m, 2H, N1-H, CR-H), 7.94 (d, 1H, CR-H), 8.10 (dd, 1H, CR-H),
8.56 (s, 1H, DMF-CH), 8.59 (dd, 1H, CR-H), 8.65 (d, 1H, CR-H), 8.76 (d, 1H, CR-H), 8.82 (br. s, 1H,
N8-H)
13

C NMR (101 MHz, CDCl3, two diastereomers) δ 11.44, 14.13, 18.78, 20.11, 20.16, 20.20, 22.67, 22.93,

23.00, 23.02, 24.52, 24.60, 25.31, 31.61, 34.69, 35.12, 41.18, 43.29, 43.38, 45.32, 45.37, 54.94, 54.96,
58.14, 58.18, 77.24, 84.02, 86.59, 86.63, 112.85, 112.87, 112.93, 120.76, 122.29, 123.62, 124.02, 126.19,
126.40, 127.73, 128.37, 128.90, 129.79, 129.87, 129.94, 158.37
31

P NMR (x MHz, CDCl3, two diastereomers) δ 148.61, 149.09

ESI-MS (positive mode): m/z calcd for C61H64O7N9P+ 1066.47 Da, observed 1066.191 Da [M]+
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2.3 Results and Discussion

For introduction of the bromine at the C8 positon of deoxyguanosine, freshly recrystallized NBS was
used; crude NBS resulted in lower yields for the reaction. In the third step of the scheme, which involved
a Mitsunobu reaction to protect the carbonyl moiety, DIAD was preferentially used in place of DEAD.
Again, DIAD resulted in better yields for the reaction. The final protection on the dG is a DMTr
protection of the free primary amine. The DMTr group is believed to facilitate the successive BuchwaldHartwig coupling reaction. This is generally attributed to the increased solubility of the dG in the reaction
as a result of the non-polar DMTr group.

After the Buchwald-Hartwig coupling, all successive products are extremely prone to degradation, as they
are acid-, light-, temperature-, and pressure-sensitive. The reactions are wrapped in aluminum foil to
prevent the products from undergoing photodecomposition. Also, if the synthesis is paused at any point,
the product is stored at -20 oC to limit the rate of degradation. At the final stage of the synthesis, the
phosphoramidite adduct is kept at -80 oC and wrapped in foil to prevent degradation.

The Buchwald-Hartwig coupling products are purified via aluminum oxide column chromatography.
This is done to prevent any degradation that the mildly acidic silica gel could potentially cause. After this
however, silica gel is used since the most acid labile group present is the DMTr group. The DMTr group
is then cleaved with an extremely dilute solution of HCl; the strength of the acid used is critical since the
N-glycosidic bond is highly acid-sensitive. The deprotection of the TBDMS ether groups was carried out
with 1M TBAF in THF, but this reaction could also be substituted with TEA•3HF. The final DMTr
protection of the 5’OH group is a critical step. The reaction mixture must be very dry in order to succeed
in the next step; as such, the starting material was thrice-co-evaporated with pyridine. Additionally, the
total time of the reaction along with the equivalents of DMT-Cl used was vital. If a large excess of DMTCl is used, the time must be monitored very carefully to ensure that protection of the 3’-OH does not
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occur. A balance of 1.2 equivalents of DMT-Cl allowed the time component to be far less important, and
given appropriate time, the reaction proceeded in good yield, without an excessive amount of product
with both hydroxyl groups protected. The final step, phosphoramidite protection of the 3’-OH is also
extremely sensitive. The starting material – which is one of the most stable products (relatively) within
the scheme – was left to dry overnight under vacuum, to ensure no moisture would be present in the
reaction. If this was not possible, the starting material was co-evaporated with methylene chloride
multiple times and then left to dry under vacuum. The phosphoramidite reaction itself was performed in a
glovebag with an argon atmosphere. The final two reactions were also purified with a basified silica gel
column; this is to prevent the acidity of the silica gel from interfering with the products that were being
separated. The synthesized phosphoramidite adduct is completely characterized (spectra show in the
following section) and is ready for incorporation into an oligomer via solid-phase oligonucleotide
synthesis.
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CHAPTER III
SYNTHESIS OF THE N2
PHOSPHORAMIDITE MONOMER OF N2(6-AMINOCHRYSENE)-5’-O-(4,4’DIMETHOXYTRITYL)-2’DEOXYGUANOSINE
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3.1 Original Synthetic Scheme for the 6-NC N2-dG Adduct
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3.2 Materials and Methods
MATERIALS
Please refer to the materials section listed in the previous chapter.
PROCEDURES

1,2-Dihydronaphtho[2,1-b]furan-1,2-diol (16) – Freshly recrystallized 2-naphthol (2.00 g, 0.0139 mol)
was added to a stirring Erlenmeyer flask of boiling deionized water (28 mL). The mixture was allowed to
stir for 3-5 mins. To the stirring Erlenmeyer flask was added KOH (0.780 g, 0.0139 mol); the solution
became homogenous and dark green. This solution was added dropwise over 1.5 h to a 500 mL round
bottom flask equipped with a stirbar containing glyoxal (24 mL, 0.209 mol) at 40 oC.

The reaction

mixture was stirred for an additional 3 h. After this time, the reaction mixture was diluted with CHCl3
(75 mL) and deionized water (75 mL). The layers were separated and the aqueous layer was extracted
with CHCl3 (2 x 75 mL). The organic layers were combined and washed with brine (1 x 50 mL). The
organic layer was retained and dried over sodium sulfate.

The solvent was removed via rotary

evaporation. The crude product was purified by silica gel flash column chromatography with a step
gradient of methanol (0-10%) in methylene chloride as the mobile phase. The product was isolated as a
yellow-orange oil (2.30 g, 85% yield).

1

H-NMR (400 MHz, DMSO-d6) δ ppm 5.25 (d, 1H, C12-H), 5.73 (d, 1H, C13-H), 5.86 (d, 1H, O15-H), 7.18

(d, 1H, C8-H), 7.35 (t, 1H, C2-H), 7.43 (d, 1H, O14-H), 7.53 (t, 1H, C1-H), 7.89 (m, 3H, C3-H, C6-H, C7-H)

13

C-NMR (101 MHz, DMSO-d6) δ ppm 77.51 (C13), 109.52 (C12), 113.23 (C8), 120.34 (C10), 123.36 (C6),

123.68 (C2), 127.60 (C1), 129.28 (C3), 129.60 (C4), 13.44 (C5), 131.70 (C7), 157.55 (C9)
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Naphtho[2,1-b]furan-2(1H)-one (17) – In a 500 mL round bottom flask equipped with a stirbar was
taken 16 (6.923 g, 0.03426 mol), CHCl3 (145 mL), and 3N HCl (175 mL). The reaction mixture was
stirred at 50 oC for 1 hr. After this time, the reaction mixture was diluted with CHCl 3 (100 mL) and
deionized water (100 mL). The layers were separated and the aqueous layer extracted with CHCl 3 (2 x
100 mL). The organic layers were combined and washed with brine (1 x 50 mL). The organic layer was
retained and dried over sodium sulfate. The solvent was removed via rotary evaporation. The crude
product was purified by silica gel flash column chromatography with a step gradient of methanol (0-5%)
in methylene chloride. The purified product was isolated as a light pink solid (5.211 g, 83% yield).

1

H-NMR (400 MHz, DMSO-d6) δ ppm 4.18 (s, 2H, C13-2H), 7.47 (m, 2H, C1-H, C8-H), 7.59 (t, 1H, C2-

H), 7.72 (d, 1H, C6-H), 7.95 (m, 2H, C3-H, C7-H)

13

C-NMR (101 MHz, DMSO-d6) δ ppm 32.73 (C13), 112.02 (C8), 118.64 (C10), 124.18 (C6), 125.40 (C2),

128.05 (C1), 129.56 (C3), 129.64 (C5), 129.79 (C7), 130.72 (C4), 152.21 (C9), 175.59 (C12)

Ethyl 2-(2-hydroxynaphthalen-1-yl)acetate (18) – In a 100 mL round bottom flask equipped with a
stirbar was taken 17 (0.451 g, 0.00245 mol), ethanol (30 mL, 0.514 mol), and sulfuric acid (5.5 mL, 0.103
mol). The reaction was refluxed for 8 hh. After this time, the mixture was allowed to cool to room
temperature and then neutralized with aqueous sodium bicarbonate. The resulting precipitate was filtered
using a Büchner funnel and washed with cold deionized water to give 18 as a light blue crystalline solid
(0.5246 g, 93% yield).

1

H-NMR (400 MHz, DMSO-d6) δ ppm 1.18 (t, 3H, C16-3H), 4.05 (s, 2H, C11-2H), 4.09 (q, 2H, C15-H),

7.20 (d, 1H, C8-H), 7.31 (t, 1H, C1-H), 7.45 (t, 1H, C6-H), 7.76 (m, 3H, C2-H, C5-H, C7-H), 9.80 (C17-H)
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13

C-NMR (101 MHz, DMSO-d6) δ ppm 14.86 (C16), 31.03 (C11), 60.74 (C15), 113.14 (C10), 118.53 (C8),

123.02 (C5), 123.28 (C1), 127.01 (C6), 128.68 (C4), 128.97 (C2), 129.06 (C7), 134.25 (C3), 153.68 (C9),
172.07 (C12)

Ethyl 2-(2-(((trifluoromethyl)sulfonyl)oxy)naphthalen-1-yl)acetate (19) – In a 25 mL round bottom
flask equipped with a stirbar was taken 18 (0.2868 g, 1.246 mmol). The flask was placed under an N2
atmosphere and then cooled to 0 oC in an ice bath; it was dissolved dry pyridine (2 mL). To the stirring
mixture at 0 oC was slowly added triflic anhydride (0.233 mL, 1.385 mmol) dropwise. After stirring at 0
o

C for 5 mins, the ice bath was removed and the flask was allowed to warm to room temperature. The

reaction mixture was allowed to stir for 25 h at room temperature. After this time, the solvent was
removed via rotary evaporation.

The crude product was purified by silica gel flash column

chromatography with a step gradient of ethyl acetate (0-20%) in hexanes as the mobile phase. The pure
product was isolated as a light yellow oil (0.449 g, 99% yield).

1

H-NMR (400 MHz, DMSO-d6) δ ppm 1.16 (t, 3H, C23-3H), 4.10 (q, 2H, C24-2H), 4.28 (s, 2H, C12-2H),

7.55 (d, C6-2H), 7.69 (m, 2H, C3-H, C7-H), 8.10 (m, 3H, C1-H, C2-H, C8-H)

13

C-NMR (101 MHz, DMSO-d6) δ ppm 14.53 (C23), 32.10 (C24), 61.50 (C12), 117.17 (C15), 119.66 (C8),

120.34 (C15) 124.00 (C10), 125.63 (C6), 127.84 (C2), 128.62 (C1), 129.34 (C3), 131.20 (C7), 132.93 (C5),
133.14 (C4), 146.02 (C9), 169.96 (C11)

19

F-NMR (376 MHz, DMSO-d6) δ ppm -73.93 (s, 3F, C15-3F)

Ethyl 2-(2-(2-formylphenyl)naphthalen-1-yl)acetate (20) – In a 25 mL round bottom flask equipped with
a stirbar was taken 19 (181 mg, 0.5 mmol) and dry dioxane (3 mL); flask was kept under an argon
atmosphere. The flask was purged for 1 hr. with argon gas at room temperature. After this time, 235

formyl

phenylboronic

acid

(90

mg,

0.6

mmol),

DavePhos

(23

mg,

6

mol

%),

and

tetrakis(triphenylphosphine)palladium(0) (46 mg, 8 mol %) was added to the flask and heated for an
additional hour at 90 oC. After this time, cesium carbonate (489 mg, 1.5 mmol) was added to the flask
and the flask was heated at 100 oC for 90 mins. The reaction was stopped at this time and the flask was
allowed to cool to room temperature. The solvent was evaporated and the crude product was purified via
silica gel flask column chromatography with ethyl acetate (0-20%) in hexanes as the mobile phase. A
combination of 20 and 21 were obtained. The product 21 is sparingly soluble in hexanes, and the
majority of it was obtained by filtering the combined fractions obtained after column chromatography;
isolated as a white powder. The filtrate was collected; the solvent removed via rotary evaporation and the
resulting green-brown viscous solid (~83.1 mg, ~55% yield) was used in the following reaction to
generate 21.

1

H-NMR (400 MHz, CDCl3) δ ppm 1.14 (t, 3H, C24-3H), 3.93 (s, 2H, C17-2H), 4.07 (q, 2H, C23-2H), 7.39

(d, 1H, C8-H), 7.44 (d, 1H, C6-H), 7.57-7.70 (m, 4H, C1-H, C2-H, C13-H, C14-H), 7.87 (d, 1H, C12-H), 7.96
(d, 1H, C3-H), 8.06 (d, 1H, C15-H), 8.11 (dd, 1H, C7-H), 9.79 (s, 1H, C21-H)

Ethyl chrysene-5-carboxylate (21) – In a 250 mL round bottom flask equipped with a stirbar was taken
the mixture of 20 and 21 (512 mg, 1.609 mmol) in ethyl alcohol (20 mL). The flask was heated to 40 oC.
To the stirring solution was added 5% KOH in water (5 mL). The reaction was monitored by thin layer
chromatography (TLC) (95:5 CH2Cl2/MeOH, v/v). After 12 hrs., the reaction mixture was filtered
through a Büchner funnel. The desired compound precipitated out of the reaction mixture and was
isolated as a white solid (329 mg, 68 % yield).

1

H-NMR (400 MHz, DMSO-d6) δ ppm 1.32 (t, 3H, C23-3H), 4.48 (q, 2H, C22-2H), 7.68-7.73 (m, 2H, C3-

H, C17-H), 7.76-7.80 (t, 1H, C16-H), 7.85-7.89 (t, 1H, C2-H), 8.15-8.29 (m, 4H, C4-H, C13-H, C15-H, C18H), 8.33 (s, 1H, C7-H), 8.96 (d, 1H, C14-H), 9.00 (d, 1H, C1-H)
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13

C-NMR (101 MHz, DMSO-d6) δ ppm 14.26 (C23), 62.09 (C22), 121.11 (C14), 123.42 (C1), 125.50 (C8),

125.90 (C3), 126.69 (C17), 127.08 (C16), 127.29 (C13), 128.51 (C2), 128.61 (C15), 128.75 (C18), 129.42
(C4), 129.54 (C11), 129.96 (C7), 130.82 (C9), 131.55 (C5), 132.28 (C10), 132.38 (C12), 133.07 (C6), 172.21
(C19).

Chrysene-5-carboxylic acid (22) – In a 25 mL round bottom flask equipped with a stirbar was taken 21
(100 mg, 0.333 mmol) dissolved in dioxane (10 mL). To it was added a solution of LiOH (100 mg, 3.330
mmol) in deionized water (5 mL). The reaction mixture was refluxed and stirred vigorously for 3 days.
Once the reaction was complete, the flask was allowed to cool to room temperature. The reaction mixture
was diluted with DI water (25 mL) and methylene chloride. Any excess starting material was removed
via extraction of the solution with methylene chloride (1 x 25ml). The organic layer was retained and
washed with DI H2O (3 x 50 mL).

The aqueous layers were combined and acidified using 37%

hydrochloric acid. The acidified aqueous layer was diluted with diethyl ether (75 mL) and washed with
DI water (1 x 75 mL). The aqueous layer was retained and extracted again with ether (3 x 50 mL). The
organic layers were combined and washed with brine (1 x 75 mL). The organic layer was retained, dried
over sodium sulfate, and the solvent removed via rotary evaporation to give the desired product as a white
solid (91 mg, 100 % yield).

1

H-NMR (400 MHz, DMSO-d6) 7.65-7.70 (m, 2H, C2-H, C11-H), 7.75 (t, 1H, C3-H), 7.83 (t, 1H, C12-H),

8.13 (d, 1H, C1-H), 8.19 (d, 2H, C4-H, C10-H), 8.27 (s, 1H, C8-H), 8.48 (d, 1H, C17-H), 8.94 (d, 1H, C13H), 8.96 (d, 1H, C16-H), 13.54 (br. s, 1H, -COOH)

13

C-NMR (101 MHz, DMSO-d6) 121.37 (C16), 123.52 (C13), 124.18 (C11), 126.07 (C2), 126.17 (C3),

126.67 (C17), 127.42 (C12), 128.21 (C4), 128.42 (C1), 128.49 (C15), 128.50 (C10), 128.80 (C7), 129.01 (C5),
129.02 (C6), 130.25 (C8), 130.36 (C9), 130.44 (C18), 132.45 (C14), 172.56 (C19)
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Chrysene-5-carbonyl chloride (23) – In a 25 mL round bottom flask equipped with a stirbar was taken 22
(52 mg, 0.19 mmol). The flask was placed under an argon atmosphere. The compound was dissolved in
anhydrous methylene chloride (15 mL); reaction mixture was cloudy white. Oxalyl chloride (0.1 mL,
0.382 mmol) was added to the flask; reaction mixture turned cloudy yellow. The reaction mixture was
allowed to stir for 2 hrs. at room temperature. Upon completion, the reaction mixture became clear. At
this point, the solvent was removed via rotary evaporation to give the pure product as a dark yellow solid
(100% yield is assumed based on yield for the following reaction – the compound was not isolated)

Chrysene-5-carboxamide (24) – In a 25 mL round bottom flask equipped with a stirbar was taken 23
(55.5 mg, 0.191 mmol). The flask was placed under an argon atmosphere, and the compound dissolved in
anhydrous methylene chloride (5 mL). NH3 was bubbled into the flask, and as the reaction progressed,
the mixture became increasingly cloudy from its initial clear yellow color. Upon completion of the
reaction, the reaction mixture was a cloudy white. After 2 h, the reaction was stopped, and the solvent
removed via rotary evaporation to give the pure product as a white solid (52 mg, 100 % yield).

1

H-NMR (400 MHz, DMSO-d6) 6.99-7.25 (br. s (rotomeric effect), 2H, N20-2H), 7.67-7.70 (m, 2H, C2-H,

C11-H), 7.76 (t, 1H, C3-H), 7.84 (t, 1H, C12-H), 8.14 (m, 1H, C1-H), 8.20 (m, 2H, C4-H, C10-H), 8.28 (s,
1H, C8-H), 8.47 (d, 1H, C17-H), 8.94 (d, 1H, C13-H), 8.97 (d, 1H, C16-H)

13

C-NMR (101 MHz, DMSO-d6)

2'-deoxyguanosine, anhydrous (26) – In a 250 mL round bottom flask equipped with a stirbar was taken
2’-deoxyguanosine monohydrate (10 g, 0.0374 mol). To it was added pyridine (150 mL). The stirring
mixture was refluxed for 5 h. After this time, the solvent was removed via rotary evaporation and the
resulting dry dG was stored under N2.
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3',5'-O-bis(tert-butyldimethylsilyl)-2'-deoxyguanosine (27) – In a 250 mL round bottom flask equipped
with a stirbar was taken 26 (15.003 g, 56.140 mmol) and imidazole (18.265 g, 268.295 mmol). The flask
was placed under an N2 atmosphere. To the flask was added dry DMF (135 mL). The reaction mixture
was left to stir at room temperature for 5-10 mins until the solution was homogenous. At this point, tertbutyldimethylsilyl chloride (23.246 g, 154.274 mmol); within 5 mins, the solution became transparent.
The mixture was left to stir at room temperature under an N2 atmosphere for 8 h. After this time, the
reaction was quenched with methanol and the solvent removed via rotary evaporation. The crude product
was diluted with methylene chloride () and deionized water (). The layers were separated and the aqueous
layer was extracted with methylene chloride (2 x 100 mL). The organic layers were combined and
washed with brine (1 x 75 mL). The organic layer was dried over Na2SO4 and the solvent removed via
rotary evaporation.

The compound was purified by silica gel flash column chromatography with

methanol (0-5%) in methylene chloride as the mobile phase. The pure product was isolated as a white
solid (21.435 g, 77%).

1

H-NMR (400 MHz, DMSO-d6) δ ppm 0.04 (s, 3H, C22-3H), 0.05 (s, 3H, C21-3H), 0.10 (s, 6H, C28-3H,

C29-3H), 0.87 (s, 9H, C24-3H, C25-3H, C26-3H), 0.89 (s, 9H, C31-3H, C32-3H, C33-3H), 2.20-2.26 (ddd, 1H,
C13-H), 2.62-2.67 (ddd, 1H, C13-H’), 3.62-3.72 (qd, 2H, C18-2H), 3.80 (m, 1H, C12-H), 4.48 (m, 1H, C16H), 6.09-6.12 (t, 1H, C14-H), 6.49 (br. s, 2H, N10-2H), 7.87 (s, 1H, C7-H), 10.63 (s, 1H, N1-H)

13

C-NMR (101 MHz, DMSO-d6) δ ppm -5.53 (C29), -5.48 (C28), -4.97 (C22), -4.79 (C21), 17.70 (C30),

17.95 (C23), 25.67 (C31, C32, C33), 25.76 (C24, C25, C26), 62.74 (C13), 72.16 (C18), 82.10 (C12), 86.98 (C14),
116.63 (C16), 121.32 (C5), 134.86 (C7), 150.97 (C4), 153.72 (C2), 156.65 (C6)

O6-benzyl-3',5'-O-bis(tert-butyldimethylsilyl)-2'-deoxyguanosine (28) – In a 500 mL flask equipped with
a stirbar was taken 27 (15.584 g, 31.434 mmol) and triphenylphosphine (14.403 g, 54.915 mmol). The
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flask was placed under an N2 atmosphere and to it was added dry dioxane (200 mL). To the stirring
reaction mixture at room temperature, benzyl alcohol (5.702 mL, 55.104 mmol) was added. Diisopropyl
azodicarboxylate (10.992 mL, 55.827 mmol) was added dropwise to the stirring mixture, which turned to
a transparent yellow within 15 mins. The reaction was allowed to continue stirring at room temperature
for 8 h under the N2 atmosphere. After this time, the solvent was evaporated. The crude compound was
purified by silica gel flash column chromatography with a step gradient of ethyl acetate (0-30%) in
hexanes as the mobile phase. The product was isolated as a white solid (8.56 g, 46 % yield).

1

H-NMR (400 MHz, CDCl3) δ ppm 0.07 (s, 3H, C34-3H), 0.08 (s, 3H, C33-3H), 0.10 (s, 6H, C35-3H, C36-

3H), 0.91 (s, 9H, C38-3H, C39-3H, C40-3H), 0.92 (s, 9H, C30-3H, C31-3H, C32-3H), 2.35-2.40 (ddd, 1H, C13H), 2.52-2.58 (ddd, 1H, C13-H’), 3.74-3.84 (qd, 2H, C18-2H), 3.96-3.99 (m, 1H, C12-H), 4.57-4.60 (m, 1H,
C16-H), 5.01 (br. s, 2H, N10-2H), 5.54-5.61 (s, 2H, C20-2H), 6.33 (t, 1H, C14-H), 7.30-7.37 (m, 3H, C23-H,
C24-H, C25-H), 7.48-7.51 (d, 2H, C22-H, C26-H), 7.93 (s, 1H, C7-H)

13

C-NMR (101 MHz, CDCl3) δ ppm -5.24 (C36), -5.13 (C35), -4.55 (C34), -4.42 (C33), 18.25 (C37), 18.67

(C29), 26.00 (C38, C39, C40), 26.21 (C30, C31, C32), 41.27 (C13), 63.00 (C18), 68.54 (C20), 72.05 (C12), 84.10
(C14), 87.96 (C16), 116.07 (C5), 128.25 (C23, C25), 128.55 (C24), 128.61 (C22, C26), 136.52 (C21), 137.99
(C7), 154.50 (C4), 158.92 (C2), 161.21 (C6)
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3.3 Results and Discussion

The N2-dG 6-nitrochrysene adduct is notably different from the C8-dG adduct due to the attachment point
of the chrysene derivative to the guanine base. It attaches at the C5 position of the aryl system as opposed
to the C6 position. It is this aspect of the adduct that makes the synthesis particularly challenging.
Chrysene preferentially reacts at the 6 and 12 positions, making the process of putting a moiety at the 5
position difficult. After attempting various schemes which generally fell short of producing initial
reactions with high yield, the scheme listed earlier was decided upon. High yields for the first few
reactions are critical, because the scheme is approximately 20 steps long (depending on how the
remainder of the scheme develops after Buchwald-Hartwig coupling). An inability to scale up the
preliminary products would make the entire scheme tedious and in general, not viable for broad
application. The other portion of the scheme, focused on development of the deoxyguanosine derivative
for Buchwald-Hartwig coupling is completed.

In order to achieve putting an aryl bromide at the C5 position of chrysene, attempts were made to simply
put any functionality at the C5 positon that could later be altered to a bromide. It is impossible to use
chrysene as a starting material, since the C5 position cannot compete with the C6 and C12 positions in
terms of reactivity. To work around this, a naphthol derivative was employed as a base for eventually
building the polyaromatic system.[27] In this scheme, β-naphthol was used in conjunction with glyoxal to
produce a diol, 16. From this, the diol was oxidized to a lactone, which was successively broken to form
an ethyl ester. At this point, the hydroxyl group at the beta position could easily be transformed to a
triflate.[28] These four reactions worked in excellent yield and served as a solid foundation for the rest of
the scheme since they are extremely easy to scale-up.

The purpose of creating the triflate is to perform a microwave Suzuki coupling that would ultimately
create the backbone for the chrysene aromatic ring system.[29,30] This reaction was originally meant to
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encompass not only the coupling to form the three ring system, but to also go further and cyclize to form
the fourth ring which would then undergo condensation to form the chrysene ethyl ester, 21 (Figure 13).
This one-pot reaction has previously been attempted for a phenanthrene system with limited success.[29]
The group achieved their best coupling and cyclization yield with ethyl esters, which is why ethanol was
chosen to break the lactone.

Figure 13: General Outline of the Suzuki coupling with Major Products

From this, a series of reactions were completed to standardize the reaction (Table 1). Originally, upon
attempting the microwave reaction using the conditions outlined, no reaction was observed. In the
beginning, Pd(PPh3)2Cl2 was used as the metal catalyst, with three equivalents of base to push the final
cyclization and condensation. Proceeding to increase the temperature (Entry 2), the reaction appeared to
have started to proceed. Attempts were made to increase the reaction time, in lieu of increasing the
temperature, but it appeared as though the high temperatures facilitated the initiation of the reaction
within a short period of time (Entries 3 and 4). Since difficulties with coupling reactions usually stem
from the palladium catalyst, a switch was made to Pd(PPHh3)4, a more reactive palladium catalyst. This
produced notably higher yields upon increases in temperature and time. However, it should be noted that
over time, a mixture a products was observed; the coupling product and the condensed product after
cyclization. Due to the high degree of similarity between these two products’ polarities, it is extremely
difficult to separate them via column chromatography; as such, yields are given as approximate ranges for
subsequent entries. Now that the reaction was starting, a higher catalyst loading was used to push it to
proceeding further. Although this did work to some extent, it was found that heating at thigh temperature
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for a long time would cause degradation of the desired product (21). In fact, 21 would undergo a form a
decarboxylation and upon purification of the reaction mixture, pure chrysene was obtained.

*Estimated yield; mixture of products measured
**Modified protocol used; base added before increase in temperature 1 hour into the
reaction
Table 1: Standardization of the Suzuki Coupling Reaction in the N2-dG Scheme

After observing this, the coupling was switched from a microwave to a batch reaction, which could
sustain heat at lower temperatures for a longer length of time. At the time, it was thought that reaction
might proceed at a lower temperature with the new palladium catalyst; catalyst loading was also increased
to better facilitate this. Entry 8 details the reaction conditions for the first batch reaction, which produced
considerably higher yields.

The Buchwald-Hartwig coupling procedure is similar to this, with the

exception of the time of addition of the base. The delay in adding the base is thought to allow for better
formation of the intermediate complex, which ultimately increase yield. Applying this thought process to
the Suzuki coupling (Entries 9-13), it was hoped that the same overall yield increase would occur. As
expected, the yield increased an additional 10%. After seeing these promising results, the catalyst loading
was dropped slightly to see if there would be a drastic impact on the reaction yield, and the ideal catalyst
loading was determined to be 8 mol %. At this time, the duration of the reaction was the final thing that
was focused on, and 1.5 h after addition of the base was determined to give the maximum yield. Since all
43

of these conditions were still producing a mixture of products, and an additional reaction (simple addition
of base with heat to promote cyclization and condensation) had to be done anyway on the portion of
product that did not cyclize and condense, the equivalents of base were also cut down to 1.5
equivalents.[31] This did not seem to affect the overall outcome of the reaction. It should be noted, that
with all of the coupling reactions presented in these syntheses, the yield did drop slightly (~5%) when the
reaction was scaled up significantly.

After standardization of the coupling reaction and subsequent cyclization/condensation, a series of
reactions were performed to produce an amide. This was accomplished through a hydrolysis of the ethyl
ester, formation of an acyl chloride, and finally bubbling of ammonia to produce the amide. These all
worked in excellent yield. It should be noted that the hydrolysis reaction is best done with LiOH as the
base.[32] Initially, the reaction was attempted with both KOH and NaOH (since they were stronger bases),
but the reaction did not proceed as readily KOH and took a significantly longer time to proceed with
NaOH. In the end, LiOH worked best; this is attributed to the lithium ion being able to better coordinate
with the oxygens in the ester since lithium is a far smaller ion. Additionally, the formation of the acyl
chloride was originally attempted with SOCl2 as a reagent[33], but upon encountering a difficult work-up,
the reagent was changed to oxalyl chloride.[34] Finally, the bubbling of ammonia[35] was decided upon, to
avoid the use of more dangerous reagents such as NaNH2.[36]

Following production of the amide, the rest of the synthesis involved a Hoffman rearrangement and
degradation to produce an aryl amine, which could then undergo Sandmeyer bromination. Ultimately,
this would put a bromine in the desired C5 position on chrysene. Then, the final reaction reprises the
nitration reaction which was already done in the prior C8-dG scheme.

The Hoffman reaction proved to be difficult. After standardizing the reaction, it was clear that a
multitude of not only the product, but byproducts and starting materials remained in the reaction
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mixture.[37] Although the product was not isolated, characteristic peaks of the product were present in the
NMR of the crude reaction mixture. Workup of the mixture through extractions eliminated the acid
formed, but the byproducts proved to be extremely difficult to separate out of the mixture. Silica gel
column chromatography resulted in the product (and other byproducts) adhering to the solid phase. This
was not entirely unsurprising due to the nitroreduction reaction that produced 6-aminochrysene in the
previous scheme. It was clear that a portion of the 6-AC did remain on the column. This was not a
problem in the prior scheme where the reaction proceeded well, so the majority of the compound came off
of the plug with a more polar solvent (such as methanol). However, the Hoffman reaction required a
proper separation, so the compounds cannot simply be forced off of the column. In an attempt to reduce
the attraction of the compound to the stationary phase, the next attempt at purification used basified silica
gel (using triethylamine). This did not yield better results. To eliminate acidity altogether, neutral
aluminum oxide was used as the stationary phase, and a proper separation was still not achieved.

As detailed in the above paragraph, the Hoffman reaction posed many difficulties, and it was not clear the
two-step Sandmeyer bromination[38] would work efficiently and in good yield as well. Further research
was done to see if these reactions could be circumvented or replaced altogether with higher yielding
reactions. An altered scheme is presented in the following sections.
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3.4 Modified Synthetic Scheme for the 6-NC N2-dG Adduct

46

47

3.5 Materials and Methods
MATERIALS
Please refer to the listed materials within the previous chapter.
P ROCEDURES
Chrysen-5-ylmethanol (38) - In an oven-dried 50 mL round bottom flask equipped with a stirbar was
taken lithium aluminum hydride (20 mg, 0.499 mmol). The flask was immediately placed under an argon
atmosphere. To it was added anhydrous THF (3 mL) and the flask was allowed to stir in an ice bath for
5-10 mins. During this time, 21 (100 mg, 0.333 mmol) was dissolved in anhydrous THF and added
dropwise to the flask containing LAH. The reaction was allowed to stir under argon at 0 oC for 2.5 h. At
this time, the flask was taken out of the ice bath. The white precipitate was filtered off and washed with
DCM. The filtrate was diluted with methylene chloride (50 mL) and deionized water (50 mL). The
aqueous layer was extracted with methylene chloride (30 mL). The combined organic layers were
washed with brine (50 mL). The organic layer was then dried over sodium sulfate, and the solvent
removed via rotary evaporation to afford the pure compound as a white solid (86 mg, 100% yield).

1

H-NMR (400 MHz, CDCl3) δ ppm 2.11 (br. s., -OH), 5.45 (s, 2H, -CH2), 7.63-7.73 (m, 4H, CR-4H), 7.97-8.03

(m, 3H, CR-3H), 8.16 (s, 1H, CR-H), 8.75 (dd, 2H, CR-2H), 8.95 (d, 1H, CR-H)

13

C-NMR (101 MHz, CDCl3) δ ppm 66.84, 121.51, 123.14, 126.09, 126.22, 126.93, 127.78, 128.18, 128.46,

129.82, 130.34, 130.47, 131.32, 133.15, 135.45.

Chrysene-5-carbaldehyde (39) – To a 500 mL round bottom flask equipped with a stirbar was taken #
(532 mg, 2.060 mmol) in methylene chloride (400 mL); the amount of solvent was maximized to increase
the speed of the reaction. To the stirring mixture was added 4-(acetylamino)-2,2,6,6-tetramethyl-1-oxopiperidinium tetrafluoroborate (Bobbitt’s Salt, 618 mg, 2.060 mmol). Upon addition of Bobbitt’s salt, the
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mixture immediately turned a bright yellow. Following this, silica gel (532 mg, 1 wt. eq. to alcohol) was
added to the mixture. The solution was allowed to stir for 10 h. The reaction was monitored by TLC
(neat methylene chloride) and upon completion, the reaction mixture turned clear and translucent. When
the reaction was complete, the solution was filtered through a silica gel plug with neat methylene chloride
to afford the product as a white solid (522 mg, 95% yield).

1

H-NMR (400 MHz, CDCl3) δ ppm 7.74-7.91 (m, 3H, CR-3H), 8.12-8.21 (m, 4H, CR-4H), 8.50 (s, 1H, CR-H),

8.81 (dd, 2H, CR-2H), 10.68 (s, 1H, -CHO)
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3.6 Results and Discussion

Initially, the scheme called for 5-bromo-6-nitrochrysene as a coupling substrate for the BuchwaldHartwig coupling. Due to difficulties encountered in that scheme, the reactant was altered to have a
triflate moiety in place of the bromide. The use of a triflate for a Buchwald-Hartwig coupling between a
PAH and a DNA nucleoside is very uncommon.[39] An amino group with an aryl bromide has been
almost exclusively used in most syntheses of this type. However, there have been many precedents in
general for joining aryl triflates and amino groups via Buchwald-Hartwig couplings.[40] Based on this, the
new scheme was conceived to circumvent both the Hoffman degradation and Sandmeyer bromination
reactions.

Starting from the ethyl 5-chrysene carboxylate, a lithium aluminum hydride reduction was performed to
produce the corresponding alcohol.[41] This reaction worked in excellent yield, without any need for
column chromatography purification. Following this, the product was oxidized to the corresponding
aldehyde. Oxidation was accomplished with Bobbitt’s salt, an oxoammonium salt which is known to be
particularly environmentally friendly.[42] It avoids the use of toxic metal catalysts such as PCC and PDC
(both chromium-containing reagents), which can contaminate water supplies, interfere with plant
physiological processes such as photosynthesis, and cause soil erosion.[43]

Taking an experimental

viewpoint, the PCC/PDC approach also involves a monotonous reaction work-up. From a synthetic
standpoint, the reaction is excellent because it is a colorimetric process and upon completion, can be
purified with a simple silica gel plug.

The reaction initially is golden-yellow in color, which

progressively turns lighter. Once complete, the reaction becomes clear and translucent.

The subsequent reaction, taking an aromatic aldehyde to an alcohol moiety directly off of the aryl ring
with loss of one carbon, is far more complex.[44] Standardization of this reaction is currently underway.
Initial attempts to conduct the reaction at room temperature yielded very slow formation of a product (not
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isolated, due to the small amount generated). Another attempt at the reaction, in refluxing conditions to
produce more product at a faster rate, resulted in a complex mixture of products. Currently, I am
attempting to identify the compounds resulted from this reaction. Additional studies will be conducted at
a slightly elevated temperature to reduce the amount of byproducts.

The successive steps in the production of the 5-trifluoromethanesulfonate-6-nitrochrysene are expected to
proceed readily and in good yield. The nitration reaction will be adapted from the C8 chrysene scheme
detailed in the previous chapter and the triflate formation will be performed in the same manner as
provided earlier in this scheme.

Following this, the Buchwald-Hartwig coupling reaction is expected to work well owing to the presence
of the nitro group on the aryl reactant. Since the aryl halide/triflate is meant to be “nucleophilic” in nature
while the organometallic compound is generally “electrophilic” in nature, the presence of electronwithdrawing groups on the aryl halide/triflate should enhance the efficiency of the coupling reaction.
This effect is mainly attributed to the oxidative portion of the catalytic cycle, which proceeds faster when
the palladium catalyst adds into electron-deficient aryl systems.

The remaining series of de-protections and re-protections to form a DNA adduct suitable for solid-phase
oligonucleotide synthesis should work well. The only problem that is anticipated is the concurrent
reduction of the benzyl ether and nitro groups. This reaction typically only serves to deprotect the
carbonyl by reducing the benzyl ether protecting group. However, it is expected to work for both groups.
In the case that it does not work or does not work efficiently, hydrazine and potentially mild heat will be
used. The second approach has been proven to work efficiently and in good yield in literature. A major
problem though is the addition of heat. Assuming that the N2 adduct is as unstable to light, heat, and acid
as the C8 adduct was, it would be preferred if the reaction could be accomplished without the addition of
heat. In a broad outlook on the scheme with the unstable nature of the compounds in mind, it is also
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recommended that the scheme not be halted at any point after the Buchwald-Hartwig coupling. Due to
the sensitive nature of the components, if the scheme must the paused, it is highly recommended that the
products be kept sealed, under argon, wrapped in aluminum foil (to prevent light exposure) within -20 oC
(if only overnight) or preferably, -80 oC (if for a period of time exceeding 12 h).
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CHAPTER IV
CONCLUSION AND FUTURE WORK
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Conclusion
These syntheses were designed and carried out to enable biological studies aimed toward understanding
the initiation phase of cancer. These studies of the carcinogens are critical, since 6-nitrochrysene, though
not as prevalent in the atmosphere as some of the other carcinogens, has been proven to be one of the
most potent carcinogens of the PAH family. This work entails the syntheses of two 6-nitrochrysene
deoxyguanosine adducts using a total synthesis approach.

The first adduct, C8-dG, has been completed in its entirety.

The Buchwald-Hartwig coupling reaction

was successful in forming the C-N bond between 6-aminochrysene and protected 8-bromo-dG. The C8CR-dG phosphoramidite monomer has been prepared, and solid-phase oligonucleotide synthesis of a 12mer has been completed.

The second project detailed was the N2-dG project. The protected dG precursor has already been
prepared and an outline for the projected scheme up to the phosphoramidite monomer has been planned
and outlined. Thus far in the projected scheme, there are three steps left before the chrysene derivative
for coupling will be prepared. The coupling is expected to occur in good yield, and the subsequent steps
are also expected to proceed readily.
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Future Work
The C8-CR-dG phosphoramidite has been used for oligonucleotide synthesis. (Figure 14):

The 12-mer is a sequence from the p53 gene, a tumor suppressor gene. This gene contains a mutational
hotspot in the codon 273, where the adduct is located - the “X” in Figure 14. Mutations in these
sequences have been detected in human cancers. So the adducted oligonucleotide will be a valuable
substrate for biological and structural studies. The oligonucleotide will be incorporated into a vector
which can be utilized in studies of both prokaryotic and eukaryotic cells.

In these studies, the

mutagenicity of the adduct will be determined. In addition, the roles played by various TLS polymerases
will be investigated.

In the N2-CR-dG adduct work, the reaction to produce 5-hydroxychrysene will soon be standardized. The
remaining two steps are expected to proceed readily as they have been completed before in prior schemes
using reasonable facsimiles of the starting materials in the N2-CR-dG scheme. Also, research is being
done to ascertain alternate routes of nitroreduction without the use of heat, in case the standard palladiumcatalyzed hydrogenation does not also work to reduce the nitro group in a later reaction of the scheme. In
a final attempt to overcome this problem, an additional step can be added to the scheme which will
separately reduce the nitro group on the chrysene ring system. As the synthesis already contains 20
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synthetic steps, this alternative will be only be used as a last resort. Aside from these two reactions, all
other steps should result in good yield. Once the phosphoramidite monomer of the N2-CR-dG adduct is
prepared, it too will be used for solid-phase synthesis.

56

References
1. Pierce, B. A. Genetics, A Conceptual Approach, 4th ed.; W. H. Freeman and Company: New
York, 2012.
2. (a) Dizdaroglu, M. Free Radical Biology & Medicine, 1991, 10, 225-242. (b) Burney, S.;
Caulfield, J. L.; Niles, J. C.; Wichnok, J. S.; Tannenbaum, S. R. Mutation Research, 1999, 424,
37-49. (c) Valko, M.; Izakovic, M.; Mazur, M.; Rhodes, C. J.; Telser, J. 2004, 266, 37-56. (d)
Wiseman, H.; Halliwell, B. Biochem. J. 1996, 313, 17-29. (e) Marnett, L. J. Carcinogenesis,
2000, 21, 361-370.
3. Bartek, Jiri; Lukas, Jiri (2001) "Mammalian G1- and S-phase checkpoints in response to DNA
damage". Current Opinion in Cell Biology 13 (6): 738–747.
4. Waters, L. S.; Minesinger, B. K.; Wiltrout, M. E.; D’Souza, S.; Woodruff, R. V.; Walker, G. C.
Microbiol. Mol. Biol. Rev. 2009, 73, 134-154.
5. Microbiol Mol Biol Rev. 2009 Mar; 73(1): 134–154.
6. Talaska, G.; Underwood, P.; Maier, A.; Lewtas, J.; Rothman, N.; Jaeger, M. Environ. Health
Perspect. 1996, 104, 901-906.
7. (a) Fromme, J. C.; Verdine, G. L. DNA Repair and Replication, 2004, 69, 1-41. (b) Krokan, H.
E.; Bjørås, M. Cold Spring Harv. Perspect. Biol., 2013, 5, 27-47.
8. (a) Sancar, A.; Tang, M. Photochemistry and Photobiology, 1993, 57, 905-921. (b) Reardon, J.
T.; Sancar, A. Progress in Nucleic Acid Research and Molecular Biology, 2005, 79, 183-235.
9. (a) Prakash, S.; Johnson, R. E.; Prakash, L. Annual Review of Biochemistry, 2005, 74, 317-353.
(b) Bienko, M.; Green, C. M.; Crosetto, N.; Rudolf, F.; Zapart, G.; Coull, B.; Kannouche, P.;
Wilder, G.; Peter, M.; Lehmann, A. R.; Hofmann, K.; Dikic, I. Science, 2005, 5755, 1821-1824.
(c) Masutani, C., Kusumoto, R., Iwai, S. and Hanaoka, F. EMBO Journal, 2000, 19, 3100–
3109. (d) McCulloch, S. D.; Kunkel, T. A. Cell Research, 2008, 18, 148-161. (e) Kai, Mihoko,
K.; Wang, T. S.-F. Genes & Dev. 2003, 17, 64-76.
10. Purohit, V.; Basu, A. K. Chem. Res. Toxicol., 2000, 8, 673-692.
11. (a) Pitts, J. N.; Jr., van Cauwenberghe, K. A.; Grosjean, D.; Schmidt, J. P.; Fitz, D. R.; Belser, W.
L.; Knudson, G. B.; Hynds, P. M. Science, 1978, 202, 515-519. (b) Jager, J. Chromatogr. 1978,
152, 573-578.
12. Dimashki, M.; Harrad, S.; Harrison, R. M. Atmospheric Environment, 2000, 15, 2459-2469.
13. (a) Phillips, R.; Daub, G.; Hunt, J. The Synthesis of Some New Azabenzo[a]pyrenes and
Monomethylazabenzo[a]pyrenes, J. Org Chem, 1972, 37, 2030-2033. (b) Patnaik, P., A
Comprehensive Guide to the Properties of Hazardous Chemical Substances. 2nd ed. 1999: John
Wiley & Sons Publishers. (c) NTP 12th Report on Carcinogens. Rep Carcinog, 2011. 12: p. 5-6,
286-291. (d) Mumtaz, M.; George, J. Toxicological Profile for Polycyclic Aromatic
Hydrocarbons. 1995
14. (a) Grantham, P.H.; Ba-Giao, N.; Mohan, L.C.; Benjamin, T.; Roller, P.P.; Weisburger, E.K. The
Metabolism of 6-Aminochrysene in Rat, European Journal of Cancer and Clinical Oncology,
1976, 12: 227-235. (b) Hodgson, R.M.; Grover, P.L.; Sims, P. European Journal of Cancer and
Clinical Oncology, 1983, 19: 1289 (c) Boyiri, T., Leszczynska, J., Desai, D., Amin, S., Nixon, D.
W. and El-Bayoumy, K. (2002), Metabolism and DNA binding of the environmental pollutant 6nitrochrysene in primary culture of human breast cells and in cultured MCF-10A, MCF-7 and
MDA-MB-435s cell lines. Int. J. Cancer, 100: 395–400.
15. Wood, A. W.; Levin, W.; Ryan, D.; Thomas, P. E.; Yagi, H.; Mah, H. D.; Thakker, D. R.; Jerina,
D. M.; Conney, A. H. Biochemical and Biophysical Research Communications, 1977, 3, 847-854.
16. (a) The Bay Region Theory of Plycyclic Aromatic Hydrocarbon Carcinogenesis. Lehr, R. E.;
Kumar, S.; Levin, W.; Wood, A. W.; Chang, R. L.; Conney, A. H.; Yagi, H.; Sayer, J. M.; Jerina,
D. M. Polycyclic Hydrocarbons and Carcinogenesis, 1985, 63-84. DOI: 10.1021/bk-19850283.ch004 (b) Balam Muñoz and Arnulfo Albores (2011). DNA Damage Caused by Polycyclic
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APPENDIX A
NMR AND MASS SPECTRA FOR
C8-CR-DG ADDUCT
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Figure 15: 1H-NMR of 6-Nitrochrysene
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Figure 16: 1H-NMR of 6-Aminochrysene
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Figure 17: 13C-NMR of 6-Aminochrysene
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Figure 18: 1H-NMR of 8-Bromo-2’-deoxyguanosine
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Figure 19: 13C-NMR of 8-Bromo-2’-deoxyguanosine
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Figure 20: 1H-NMR of 8-Bromo-3',5'-O-bis(tert-butyldimethylsilyl)-2'-deoxyguanosine
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Figure 21: 13C-NMR of 8-Bromo-3',5'-O-bis(tert-butyldimethylsilyl)-2'-deoxyguanosine
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Figure 22: 1H-NMR of O6-Benzyl-8-bromo-3',5'-O-bis(tert-butyldimethylsilyl)-2'-deoxyguanosine
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Figure 23: 13C-NMR of O6-Benzyl-8-bromo-3',5'-O-bis(tert-butyldimethylsilyl)-2'-deoxyguanosine
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Figure 24: 1H-NMR of O6-Benzyl-8-bromo-3',5'-O-bis(tert-butyldimethylsilyl)-N2-dimethoxytrityl2'-deoxyguanosine
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Figure 25: 13C-NMR of O6-Benzyl-8-bromo-3',5'-O-bis(tert-butyldimethylsilyl)-N2-dimethoxytrityl2'-deoxyguanosine
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Figure 26: 1H-NMR of 8-(N-6-Aminochrysene)-O6-benzyl-3',5'-O-bis(tert-butyldimethylsilyl)-N2dimethoxytrityl-2'-deoxyguanosine
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Figure 27: 13C-NMR of 8-(N-6-Aminochrysene)-O6-benzyl-3',5'-O-bis(tert-butyldimethylsilyl)-N2dimethoxytrityl-2'-deoxyguanosine
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Figure 28: Mass Spectrum of 8-(N-6-Aminochrysene)-O6-benzyl-3',5'-O-bis(tert-butyldimethylsilyl)N2-dimethoxytrityl-2'-deoxyguanosine
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Figure 29: 1H-NMR of 8-(N-6-Aminochrysene)-O6-benzyl-3',5'-O-bis(tert-butyldimethylsilyl)-2'deoxyguanosine
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Figure 30: 13C-NMR of 8-(N-6-aminochrysene)-O6-benzyl-3',5'-O-bis(tert-butyldimethylsilyl)-2'deoxyguanosine
76

Figure 31: Mass Spectrum of 8-(N-6-Aminochrysene)-O6-benzyl-3',5'-O-bis(tert-butyldimethylsilyl)2'-deoxyguanosine
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Figure 32: 1H-NMR of 8-(N-6-Aminochrysene)-3',5'-O-bis(tert-butyldimethylsilyl)-2'-deoxyguanosine
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Figure 33: 13C-NMR of 8-(N-6-Aminochrysene)-3',5'-O-bis(tert-butyldimethylsilyl)-2'-deoxyguanosine
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Figure 34: Mass Spectrum of 8-(N-6-Aminochrysene)-3',5'-O-bis(tert-butyldimethylsilyl)-2'deoxyguanosine
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Figure 35: 1H-NMR of 8-(N-6-Aminochrysene)-3',5'-O-bis(tert-butyldimethylsilyl)-N2-DMF-2'deoxyguanosine
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Figure 36: 13C-NMR of 8-(N-6-Aminochrysene)-3',5'-O-bis(tert-butyldimethylsilyl)-N2-DMF-2'deoxyguanosine
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Figure 37: Mass Spectrum of 8-(N-6-Aminochrysene)-3',5'-O-bis(tert-butyldimethylsilyl)-N2-DMF-2'deoxyguanosine
83

Figure 38: 1H-NMR of 8-(N-6-Aminochrysene)-N2-DMF-2'-deoxyguanosine
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Figure 39: 13C-NMR of 8-(N-6-Aminochrysene)-N2-DMF-2'-deoxyguanosine
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Figure 40: Mass Spectrum of 8-(N-6-Aminochrysene)-N2-DMF-2'-deoxyguanosine
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Figure 41: 1H-NMR of 8-(N-6-Aminochrysene)-N2-DMF-5’-O-(4,4’-dimethoxytrityl)-2’deoxyguanosine
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Figure 42: 13C-NMR of 8-(N-6-Aminochrysene)-N2-DMF-5’-O-(4,4’-dimethoxytrityl)-2’deoxyguanosine
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Figure 43: Mass Spectrum of 8-(N-6-Aminochrysene)-N2-DMF-5’-O-(4,4’-dimethoxytrityl)-2’deoxyguanosine
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Figure 44: 1H-NMR of 8-(N-6-Aminochrysene)-N2-DMF-5’-O-(4,4’-dimethoxytrityl)-3’-cyanoethyl-2’deoxyguanosine phosphoramidite
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Figure 45: 13C-NMR of 8-(N-6-Aminochrysene)-N2-DMF-5’-O-(4,4’-dimethoxytrityl)-3’-cyanoethyl-2’deoxyguanosine phosphoramidite
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Figure 46: 31P-NMR of 8-(N-6-Aminochrysene)-N2-DMF-5’-O-(4,4’-dimethoxytrityl)-3’-cyanoethyl-2’deoxyguanosine phosphoramidite
92

Molecular Weight: 1066.191

Figure 47: Mass Spectrum of 8-(N-6-Aminochrysene)-N2-DMF-5’-O-(4,4’-dimethoxytrityl)-3’cyanoethyl-2’-deoxyguanosine phosphoramidite
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APPENDIX B
NMR AND MASS SPECTRA FOR
N2-CR-DG ADDUCT
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Figure 48: 1H-NMR of 1,2-Dihydronaphtho[2,1-b]furan-1,2-diol
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Figure 49: 13C-NMR of 1,2-Dihydronaphtho[2,1-b]furan-1,2-diol
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Figure 50: Mass Spectrum of 1,2-Dihydronaphtho[2,1-b]furan-1,2-diol
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Figure 51: 1H-NMR of Naphtho[2,1-b]furan-2(1H)-one
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Figure 52: 13C-NMR of Naphtho[2,1-b]furan-2(1H)-one
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Figure 53: Mass Spectrum of Naphtho[2,1-b]furan-2(1H)-one
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Figure 54: 1H-NMR of Ethyl 2-(2-hydroxynaphthalen-1-yl)acetate
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Figure 55: 13C-NMR of Ethyl 2-(2-hydroxynaphthalen-1-yl)acetate
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Figure 56: Mass Spectrum of Ethyl 2-(2-hydroxynaphthalen-1-yl)acetate
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Figure 57: 1H-NMR of Ethyl 2-(2-(((trifluoromethyl)sulfonyl)oxy)naphthalen-1-yl)acetate

104

Figure 58: 13C-NMR of Ethyl 2-(2-(((trifluoromethyl)sulfonyl)oxy)naphthalen-1-yl)acetate
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Figure 59: 19F-NMR of Ethyl 2-(2-(((trifluoromethyl)sulfonyl)oxy)naphthalen-1-yl)acetate
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Figure 60: Mass Spectrum of Ethyl 2-(2-(((trifluoromethyl)sulfonyl)oxy)naphthalen-1-yl)acetate
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Figure 61: 1H-NMR of Ethyl 2-(2-(2-formylphenyl)naphthalen-1-yl)acetate
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Figure 62: 1H-NMR of Ethyl chrysene-5-carboxylate
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Figure 63: 13C-NMR of Ethyl chrysene-5-carboxylate
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Figure 64: Mass Spectrum of Ethyl chrysene-5-carboxylate
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Figure 65: 1H-NMR of Chrysene-5-carboxylic acid
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Figure 66: 13C-NMR of Chrysene-5-carboxylic acid
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Figure 67: 1H-NMR of Chrysene-5-carboxamide
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Figure 68: 1H-NMR of 3',5'-O-Bis(tert-butyldimethylsilyl)-2'-deoxyguanosine
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Figure 69: 13C-NMR of 3',5'-O-Bis(tert-butyldimethylsilyl)-2'-deoxyguanosine
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Figure 70: 1H-NMR of O6-Benzyl-3',5'-O-bis(tert-butyldimethylsilyl)-2'-deoxyguanosine
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Figure 71: 13C-NMR of O6-Benzyl-3',5'-O-bis(tert-butyldimethylsilyl)-2'-deoxyguanosine
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Figure 72: 1H-NMR of Chrysen-5-ylmethanol
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Figure 73: 13C-NMR of Chrysen-5-ylmethanol
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Figure 74: Mass Spectrum of Chrysen-5-ylmethanol
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Figure 75: 1H-NMR of Chrysene-5-carbaldehyde
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